Non-rheumatic valve diseases

I9_NONRHEVALV

heart valve disease: A disease involving the cardial valve.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I34, I35, I36, I37 Hospital discharge: ICD-9 — 424 Hospital discharge: ICD-8 — 39[4-6]\|424 Hospital discharge: excluded ICD-8 — 4249\|3940\|3950\|3960\|3970 Cause of death: ICD-10 — I34, I35, I36, I37 Cause of death: ICD-9 — 424 Cause of death: ICD-8 — 39[4-6]\|424 Cause of death: excluded ICD-8 — 4249\|3940\|3950\|3960\|3970 2 out of 7 registries used, show all original rules.	29335
4. Check minimum number of events None	29335
5. Include endpoints None	29335
6. Filter based on genotype QC (FinnGen only)	29335

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_NONRHEVALV
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I3[4-7]
HD_ICD_9	424
HD_ICD_8	39[4-6]\|424
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	4249\|3940\|3950\|3960\|3970
COD_MAINONLY
COD_ICD_10	I3[4-7]
COD_ICD_9	424
COD_ICD_8	39[4-6]\|424
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	4249\|3940\|3950\|3960\|3970
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-rheumatic valve diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	215676	107164	106544
Only index persons	175595	87966	87629
Unadjusted period prevalence (%)
Whole population	3.01	3.07	2.98
Only index persons	3.29	3.23	3.35
Median age at first event (years)
Whole population	71.82	74.38	69.26
Only index persons	71.28	73.70	68.86

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29335	12602	16733
Unadjusted period prevalence (%)	6.05	4.30	7.38
Median age at first event (years)	69.27	69.61	69.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13749: Matched controls
119160

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

323.0

446

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

99.5

323.0

729

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.4

323.0

5577

8916

B01AA03

ATC

warfarin; systemic

18.9

323.0

5376

3914

I49.5

ICD-10 Finland

Sick sinus syndrome

358.1

323.0

520

XF640

NOMESCO Finland

18.8

323.0

896

439

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

25.0

323.0

3100

1370

WX872

NOMESCO Finland

Intensive care

12.9

323.0

1891

1459

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

17.3

323.0

7278

7284

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

1926.7

323.0

448

I50.1

ICD-10 Finland

Left ventricular failure

4438.3

323.0

972

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

165.9

323.0

962

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.8

323.0

3119

11305

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1426.1

323.0

465

C09AA05

ATC

ramipril; oral

2.9

323.0

3763

13747

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

1677.4

323.0

703

I50.9

ICD-10 Finland

Heart failure, unspecified

133.0

323.0

2522

201

I48

ICD-10 Finland

Atrial fibrillation and flutter

207.2

323.0

4455

275

B01AF02

ATC

apixaban; oral

13.6

323.0

1417

998

201

Kela drug reimbursment

Chronic cardiac insufficiency

27.0

323.0

1084

377

I34.1

ICD-10 Finland

Mitral (valve) prolapse

596.0

323.0

2764

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

323.0

775

R06.0

ICD-10 Finland

Dyspnoea

2.8

323.0

3639

13590

C01BC04

ATC

flecainide; systemic

116.9

323.0

532

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

972.2

323.0

2487

C07AB07

ATC

bisoprolol; oral

6.0

323.0

8647

26197

C03DA01

ATC

spironolactone; oral

5.8

323.0

1890

3199

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.6

323.0

1670

2428

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

6.2

323.0

1001

1483

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

166.0

323.0

709

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

819.8

323.0

1518

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

323.0

884

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

398.3

323.0

947

XF404

NOMESCO Finland

Ambulatory ECG

13.2

323.0

2079

1582

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2869.0

323.0

332

I35.0

ICD-10 Finland

Aortic (valve) stenosis

447.5

323.0

4071

113

XF402

NOMESCO Finland

ECG with work load test

4.7

323.0

2252

4774

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

45.3

323.0

891

182

I47.2

ICD-10 Finland

Ventricular tachycardia

211.6

323.0

403

K83

ICPC

Heart valve disease NOS

254.0

323.0

667

I47.1

ICD-10 Finland

Supraventricular tachycardia

45.2

323.0

647

130

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

516.5

323.0

682

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

856.6

323.0

3594

AN1

Coronary angiography

5.7

323.0

2229

3890

Q23.11

ICD-10 Finland

Bicuspid aortic valve

122.0

323.0

796

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

106.0

323.0

839

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.9

323.0

2250

7410

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

323.0

7526

30139

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

600.3

323.0

4553

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

4437.6

323.0

1411

C07AB02

ATC

metoprolol; systemic

2.9

323.0

2869

9866

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

323.0

457

B01AB05

ATC

enoxaparin; parenteral

2.2

323.0

4479

21273

C03CA01

ATC

furosemide; systemic

5.8

323.0

4881

10290

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

27.7

323.0

1307

450

K78

ICPC

Atrial fibrillation/flutter

34.5

323.0

1331

369

XFE00

NOMESCO Finland

Epicardial ultrasonography

15.2

323.0

667

398

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

264.9

323.0

1248

I49.3

ICD-10 Finland

Ventricular premature depolarization

17.5

323.0

1172

631

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

131.6

323.0

1294

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

1766.1

323.0

413

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

8.7

323.0

828

870

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

12.7

323.0

5186

5408

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

323.0

2125

207

Kela drug reimbursment

Chronic arrhythmias

375.7

323.0

2778

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

12.4

323.0

2738

2347

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

35.3

323.0

2220

647

TFP20

NOMESCO Finland

Cardiodefibrillation

351.3

323.0

1875

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.3

323.0

3460

8691

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

323.0

717

I50.0

ICD-10 Finland

Congestive heart failure

233.7

323.0

1251

TFP34

NOMESCO Finland

Electrophysiological investigation

389.6

323.0

605

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1620.8

323.0

565

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

323.0

1408

2618

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

585.5

323.0

1616

C01AA05

ATC

digoxin; systemic

29.1

323.0

1417

468

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.5

323.0

3455

6801

C01BD01

ATC

amiodarone; systemic

442.1

323.0

728

I48.1

ICD-10 Finland

Persistent atrial fibrillation

669.1

323.0

449

PD5BD

NOMESCO Finland

Extensive CT of aorta

14.8

321.9

575

351

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

21.6

321.8

501

208

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2769.3

315.2

321

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

314.3

7764

47045

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

411.6

309.1

326

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

308.0

2388

8401

C01DA14

ATC

isosorbide mononitrate; oral

3.3

306.0

1741

4959

K84

ICPC

Heart disease other

11.2

300.1

608

491

AC4

MVP

+∞

298.8

302

ZXE20

NOMESCO Finland

More than three and less than five hours

2.8

296.8

2299

8064

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

44.4

294.9

384

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

290.0

1730

5091

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.5

286.1

1110

2256

I50

ICD-10 Finland

Heart failure

34.5

282.0

387

100

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

280.4

3724

17273

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

8.3

280.1

672

737

ZXD05

NOMESCO Finland

Urgent procedure

2.1

278.1

4026

19389

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

86.0

271.8

320

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

271.0

274

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

418.6

270.3

285

TFP35

NOMESCO Finland

Electroanatomical mapping

615.7

267.7

279

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

9.4

267.0

594

572

AB1

AVR mechanical

2309.2

264.6

270

AA1AD

NOMESCO Finland

CT of head and brain

2.2

257.2

3113

13745

C10AA05

ATC

atorvastatin; oral

1.9

255.1

5318

29375

Angiography of the heart and coronary arteries

5.2

253.6

860

1507

C07AA07

ATC

sotalol; systemic

10.4

251.5

528

456

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

244.2

247

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

326.0

244.2

260

WX892

NOMESCO Finland

Monitored bed care

3.7

244.0

1175

2903

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

234.3

237

I49.1

ICD-10 Finland

Atrial premature depolarization

12.6

229.7

439

312

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

150.7

229.6

256

I44.1

ICD-10 Finland

Atrioventricular block, second degree

306.6

229.5

245

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

227.8

3917

19907

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

225.0

2809

12473

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

215.2

224.3

244

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.7

221.9

692

1095

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.4

219.1

2127

8345

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

217.4

970

2235

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

1835.0

212.2

217

K99

ICPC

Cardiovascular disease other

9.0

211.9

482

481

N02BE01

ATC

paracetamol; systemic, rectal

2.0

210.6

11332

83795

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

210.2

3829

19770

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

209.5

212

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

207.2

1740

6289

AB2

AVR bio, stent

+∞

206.5

209

B01AC04

ATC

clopidogrel; oral

2.4

201.8

1920

7425

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.5

200.4

1050

2764

K80

ICPC

Cardiac arrhythmia NOS

3.8

199.8

926

2202

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

369.5

199.2

211

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

195.6

198

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

190.7

193

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

12.4

190.4

366

263

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.2

190.3

801

1744

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

78.9

188.4

224

C10AA01

ATC

simvastatin; oral

1.7

188.1

5536

33277

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.8

184.7

868

2085

B01AE07

ATC

dabigatran etexilate; oral

7.2

184.4

483

603

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

183.7

186

205

Kela drug reimbursment

Chronic hypertension

1.9

183.2

3429

17709

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

8.1

183.2

443

489

SPAT1097

SPAT

Recording of ECG

2.3

182.1

1948

7959

C08CA01

ATC

amlodipine; oral

1.8

181.9

4447

25149

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.1

180.6

1098

3220

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.4

177.1

702

1441

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

537.3

175.9

184

K77

ICPC

Heart failure

33.4

175.3

242

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

13.2

173.6

324

218

PD5AD

NOMESCO Finland

CT of aorta

11.0

173.0

352

285

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

35.7

172.9

235

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1626.8

172.6

177

I35.8

ICD-10 Finland

Other aortic valve disorders

131.1

172.1

194

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

171.8

174

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

171.8

174

AS4

Physiological pacemaker insertion DDD (R)

395.6

171.3

181

AQ1

Conventional electrophysiological examination

314.0

168.8

180

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

69.1

168.6

204

I25.2

ICD-10 Finland

Old myocardial infarction

3.9

168.1

750

1719

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

168.0

2629

12634

B01AF01

ATC

rivaroxaban; oral

2.6

166.4

1416

5119

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

165.9

168

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

164.9

167

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

44.4

163.2

212

SPAT1263

SPAT

Sampling

1.7

161.7

5158

31314

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

731.4

160.9

167

GD1LA

NOMESCO Finland

29.1

159.9

228

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

158.8

1194

4009

A02BC02

ATC

pantoprazole; systemic

1.6

156.6

8251

57189

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

153.9

3620

19985

R04.0

ICD-10 Finland

Epistaxis

3.1

153.1

942

2776

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

30.2

152.9

216

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

353.3

152.7

162

M04AA01

ATC

allopurinol; systemic

2.4

151.9

1518

5958

C09DX04

ATC

valsartan and sacubitril; oral

1405.4

151.9

156

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

67.4

151.6

184

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.6

151.3

475

754

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1384.6

149.9

154

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

30.3

148.8

210

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

344.3

148.8

158

R55

ICD-10 Finland

Syncope and collapse

2.5

148.0

1262

4550

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

147.8

2738

13919

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

146.9

1031

3313

342

Kela drug reimbursment

Dronedarone

+∞

146.1

148

TK800

NOMESCO Finland

Hemodialysis

6.4

145.3

412

574

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

144.9

1314

4897

AP1

Catheterization of the left side of the heart

10.4

143.1

299

255

J01CA04

ATC

amoxicillin; systemic

1.7

141.7

10314

76701

I97.0

ICD-10 Finland

Postcardiotomy syndrome

67.9

140.3

170

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

139.9

1975

9038

WX402

NOMESCO Finland

General anaesthesia

1.9

138.6

2306

11242

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

148.9

137.3

153

WW502

NOMESCO Finland

Autotransfusion

22.3

135.6

208

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

135.5

1005

3335

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.3

135.4

348

422

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

134.6

5234

33030

Catheterization and pressure measurement of the left side of the heart

10.1

134.3

284

248

C08DA01

ATC

verapamil; systemic

4.7

134.0

497

951

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

20.5

133.4

210

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

1210.4

133.1

137

C10AX09

ATC

ezetimibe; oral

2.2

132.8

1590

6771

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

129.6

4815

29947

ZXE00

NOMESCO Finland

One hour or less

1.6

128.3

4796

29851

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

44.9

126.7

164

R02

ICPC

Shortness of breath/dyspnoea

2.2

126.7

1386

5654

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

126.5

1685

7500

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

125.8

797

2387

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

125.6

922

3037

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

571.8

125.4

131

C01BD07

ATC

dronedarone; oral

+∞

124.4

126

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

562.9

123.5

129

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

558.5

122.5

128

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.7

121.5

588

1439

FL1AC

NOMESCO Finland

Left cardioangiography

8.6

121.3

280

286

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.1

121.0

354

514

Catheterization and pressure measurement of the right side of the heart

109.0

119.6

137

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

119.4

1230

4869

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

1074.6

119.3

123

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

117.3

1042

3820

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

527.6

115.6

121

R00.2

ICD-10 Finland

Palpitations

2.8

115.2

814

2613

C09AA02

ATC

enalapril; systemic

1.8

115.0

2325

12050

AP3

Catheterization of the right and left side of the heart

158.6

114.6

127

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.4

114.2

600

1568

Z50.0

ICD-10 Finland

Cardiac rehabilitation

10.1

113.4

240

210

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

112.5

114

I44.0

ICD-10 Finland

Atrioventricular block, first degree

25.2

111.0

164

R4110

NOMESCO Finland

Physiotherapy

1.6

110.5

3343

19508

UJF32

NOMESCO Finland

Coloscopy

1.7

110.2

3112

17818

B01AF03

ATC

edoxaban; oral

22.1

110.1

169

SPAT1301

SPAT

No procedures

1.6

109.9

3629

21670

R42

ICD-10 Finland

Dizziness and giddiness

1.8

108.0

2349

12434

I48.3

ICD-10 Finland

Typical atrial flutter

173.3

108.0

119

N02AX02

ATC

tramadol; systemic, rectal

1.5

107.7

5253

34429

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

107.1

551

1416

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

168.9

105.1

116

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

104.6

827

2839

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

104.5

3410

20247

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

144.8

103.9

116

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

103.9

902

3260

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

103.1

810

2768

H02AB06

ATC

prednisolone; systemic

1.5

102.9

5525

36870

FKC00

NOMESCO Finland

Repair of mitral valve for insufficiency using ring

+∞

102.6

104

AP2

Catheterization of the right side of the heart

64.4

102.6

125

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.3

102.5

337

565

C09CA01

ATC

losartan; oral

1.7

102.4

2942

16868

R50.9

ICD-10 Finland

Fever, unspecified

1.9

100.9

1622

7728

I20.09

ICD-10 Finland

Unstable angina

3.0

100.8

621

1821

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.1

100.8

609

1762

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

907.2

100.6

104

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

100.3

1489

6879

Q25.1

ICD-10 Finland

Coarctation of aorta

41.4

97.5

128

C08DB01

ATC

diltiazem; oral

3.3

97.5

542

1477

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

96.7

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

154.2

95.5

106

I38

ICD-10 Finland

Endocarditis, valve unspecified

+∞

94.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.0

94.5

278

407

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

94.3

1017

4097

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

845.6

93.7

WZC30

NOMESCO Finland

Teaching

1.8

92.8

1748

8785

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

176.3

91.9

101

Z2221

NOMESCO Finland

Medical doctor

1.6

91.5

3136

18738

N18.8

ICD-10 Finland

Other chronic renal failure

4.5

91.4

349

687

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

68.7

91.2

110

I37.0

ICD-10 Finland

Pulmonary valve stenosis

819.2

90.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

90.8

4593

30014

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.7

90.7

425

1011

AA1

Conventional CABG

6.7

90.4

245

321

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

90.4

395

884

C07AG02

ATC

carvedilol; oral

2.6

90.3

716

2456

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

810.4

89.8

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

88.8

2739

15910

M10.9

ICD-10 Finland

Gout, unspecified

2.6

88.8

713

2463

AQ2

Electrophysiological electroanatomical examination

+∞

88.8

R53

ICD-10 Finland

Malaise and fatigue

1.7

88.5

1968

10422

C08CA02

ATC

felodipine; oral

2.2

88.4

1036

4328

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

5.2

88.4

293

496

C07AB03

ATC

atenolol; systemic

2.7

88.2

638

2074

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

+∞

87.8

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

86.9

730

2586

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

85.8

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

85.8

J01FF01

ATC

clindamycin; systemic

1.5

85.7

3225

19664

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

34.0

85.6

117

A12BA01

ATC

potassium chloride; oral

3.5

85.0

437

1121

Aortic Valve Replacement (AVR)

766.5

84.9

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

84.8

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

25.8

84.7

124

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

7.5

84.6

212

248

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

84.3

2456

14028

K04

ICPC

Palpitations/awareness of heart

3.0

84.0

529

1571

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

83.8

A46

ICD-10 Finland

Erysipelas

1.8

83.7

1524

7555

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

10.1

83.6

176

153

SPAT1325

SPAT

Vaccination

1.5

83.4

3733

23651

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

+∞

82.9

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

82.9

K05

ICPC

Irregular heartbeat other

4.5

82.7

312

607

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

82.4

412

1034

K29

ICPC

Cardiovascular sympt/complt other

3.1

82.0

493

1420

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

81.9

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

8.2

81.8

194

208

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

81.7

719

2611

ZX120

NOMESCO Finland

Intravenous

2.0

81.5

1130

5063

C10AA07

ATC

rosuvastatin; oral

1.5

81.4

3081

18768

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.9

81.4

361

819

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.5

80.3

223

303

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

80.1

448

1226

SPAT1260

SPAT

Consultation of another employee

1.7

79.1

2061

11398

A11CC03

ATC

alfacalcidol; systemic

4.3

79.0

316

652

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

74.6

78.8

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

705.0

78.0

I35

ICD-10 Finland

Nonrheumatic aortic valve disorders

98.1

78.0

1CX08

NOMESCO Finland

150.0

77.4

XF622

NOMESCO Finland

Measurement of minute volume of heart

22.7

77.1

117

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.5

77.0

213

288

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

76.9

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

76.4

4267

28197

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

75.9

2465

14435

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

180.9

75.7

L04AA06

ATC

mycophenolic acid; systemic

4.3

75.6

300

614

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

75.2

1252

6002

SPAT1153

SPAT

Removal of sutures

1.5

74.3

3834

24900

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

74.1

3673

23653

SPAT1310

SPAT

Counselling related to known health issue

1.5

73.9

3673

23664

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.2

72.6

417

1161

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.3

71.7

382

1008

S18

ICPC

Laceration/cut

1.4

71.6

4924

33744

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

11.9

71.5

138

101

FM1DE

SPAT

22.1

71.4

109

C08CA13

ATC

lercanidipine; oral

1.8

71.3

1459

7490

5273

FHL

Repair with flap prosthesis or graft

+∞

71.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

70.7

4958

34070

Electrophysiological Special Examination

73.3

70.4

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

30.5

70.1

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

70.0

3900

25649

J01DB01

ATC

cefalexin; oral

1.4

70.0

10151

79146

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.5

69.3

347

872

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

69.0

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

69.0

2311

13596

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

165.5

68.9

A41.9

ICD-10 Finland

Sepsis, unspecified

3.1

68.9

412

1182

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.8

68.8

243

442

127

Kela drug reimbursment

Transplant complication

4.4

68.4

267

538

3A064

NOMESCO Finland

29.9

68.3

C10AA03

ATC

pravastatin; oral

2.1

67.4

789

3284

Mitral valve plasty

+∞

67.1

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.8

66.8

300

689

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

307.2

66.7

AR5

Catheter ablation of arrhythmia, target: atrial flutter

599.7

66.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

66.1

4278

28871

C02EA02

ATC

2.9

65.8

436

1340

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

63.5

65.7

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.8

65.5

296

683

SPAT1254

SPAT

Administration of medicine

1.8

65.5

1376

7110

SPAT1104

SPAT

Monitoring of emergency patient

2.2

65.1

717

2903

5253

FHL

Cardiac lung machine

15.9

65.0

111

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

64.8

621

2353

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.7

64.4

463

1496

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

14.4

64.3

114

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

64.2

2170

12770

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

63.9

587

2176

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.7

63.9

157

179

J01MA12

ATC

levofloxacin; systemic

1.6

63.7

2008

11609

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

63.7

365

1016

AD1

TVP

+∞

63.1

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

+∞

63.1

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

63.1

Q21.10

ICD-10 Finland

Persistent ostium secundum

12.0

63.0

121

Catheter ablation of arrhythmia

197.3

62.4

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.3

62.3

633

2467

AS2

Ventricular pacemaker insertion VVI (R)

564.7

62.3

I45.9

ICD-10 Finland

Conduction disorder, unspecified

39.7

62.2

A12AA04

ATC

calcium carbonate; oral

4.8

62.0

222

410

SPAT1312

SPAT

General health counselling

1.4

61.7

3594

23713

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.6

61.6

486

1658

G45.3

ICD-10 Finland

Amaurosis fugax

4.1

61.6

257

553

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

61.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

61.1

1003

4769

FXZ00

NOMESCO Finland

Off-pump cardiac operation

11.8

61.1

118

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

61.0

1845

10548

R07.3

ICD-10 Finland

Other chest pain

1.9

60.9

1006

4793

I51.4

ICD-10 Finland

Myocarditis, unspecified

88.4

60.9

K22

ICPC

Risk factor cardiovascular disease

2.3

60.8

617

2404

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.5

60.6

227

440

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

60.5

529

1910

XF409

NOMESCO Finland

Other special ECG

30.5

60.2

N19

ICD-10 Finland

Unspecified kidney failure

3.5

60.1

304

771

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.9

59.7

381

1143

I42.8

ICD-10 Finland

Other cardiomyopathies

188.6

59.5

AC1

MVR mechanical

+∞

59.2

A28

ICPC

Limited function/disability NOS

1.8

58.8

1166

5907

SPAT1255

SPAT

Intravenous administration of medicine

2.1

58.7

708

2984

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

22.2

58.5

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

58.2

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

58.2

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

37.2

57.7

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

57.6

3225

21068

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

57.5

238

508

S97

ICPC

Chronic ulcer skin

2.4

57.5

522

1923

C03AA03

ATC

hydrochlorothiazide; oral

1.8

57.5

1008

4900

Q87.4

ICD-10 Finland

Marfan syndrome

40.8

57.3

Q21.30

ICD-10 Finland

Tetralogy of Fallot

113.2

57.2

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

57.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

57.1

1811

10462

AJ2

Reconstruction of the ascending aorta

48.2

56.7

211

AVR mechanical

512.1

56.4

K92.1

ICD-10 Finland

Melaena

2.4

56.3

520

1934

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

19.4

56.1

C08CA05

ATC

nifedipine; systemic

2.1

56.0

654

2715

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.6

56.0

435

1473

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.7

55.9

170

261

C02AC05

ATC

moxonidine; oral

2.4

55.8

494

1796

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

55.5

517

1929

C09CA06

ATC

candesartan; oral

1.5

55.3

2397

14861

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

+∞

55.2

A40.8

ICD-10 Finland

Other streptococcal sepsis

7.5

54.8

136

158

WX720

NOMESCO Finland

Own respiration

2.5

54.4

461

1638

4241B

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]

+∞

54.2

R31

ICD-10 Finland

Unspecified haematuria

1.8

54.1

938

4541

C09CA03

ATC

valsartan; oral

1.8

54.0

987

4864

Z94.1

ICD-10 Finland

Heart transplant status

36.9

53.9

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

38.6

53.7

TFJ02

NOMESCO Finland

Muscle biopsy of heart

485.9

53.5

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

106.2

53.4

FM1CD

NOMESCO Finland

Very extensive CT of heart

28.4

52.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

52.6

1566

8891

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

477.1

52.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

52.5

1347

7352

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

+∞

52.3

FFM30

NOMESCO Finland

Occlusion of atrial appendage internally by internal suture ligation

+∞

52.3

FPD96

NOMESCO Finland

Other operation for atrial fibrillation

+∞

52.3

XF405

NOMESCO Finland

Symptom ECG

9.7

52.1

111

100

I20.00

ICD-10 Finland

Unstable angina

3.2

51.9

291

799

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

19.3

51.7

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.4

51.6

486

1825

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

51.5

2940

19208

FM1AD

NOMESCO Finland

CT of heart

41.6

51.5

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

+∞

51.3

742

NOMESCO Finland

27.6

51.1

A41.8

ICD-10 Finland

Other specified sepsis

4.3

51.1

203

418

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

51.0

1338

7347

Congenital heart failure surgery

50.6

50.9

R60.0

ICD-10 Finland

Localized oedema

1.8

50.7

1042

5329

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

50.6

460

1695

A02BC01

ATC

omeprazole; systemic

1.4

50.6

2971

19498

I36.9

ICD-10 Finland

Nonrheumatic tricuspid valve disorder, unspecified

+∞

50.3

V03AE02

ATC

sevelamer; oral

9.5

50.2

108

WX882

NOMESCO Finland

High dependency care

2.8

49.9

341

1067

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

159.5

49.9

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.5

49.7

409

1430

TK810

NOMESCO Finland

Hemofiltration

8.6

49.5

113

115

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

49.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

49.0

807

3835

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

64.3

48.7

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

72.1

48.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

48.5

1035

5349

WX002

NOMESCO Finland

Sedation and analgesia

1.5

48.5

2176

13542

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.8

48.4

170

309

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

48.4

578

2422

FKC10

NOMESCO Finland

Suture of cleft mitral leaflet

+∞

48.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

48.2

331

1040

I20.01

ICD-10 Finland

Unstable angina

3.1

48.2

288

827

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

48.2

676

3025

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3019069) Monocytes/100 leukocytes in Blood

11671

62687

1.69

322.61

7.4

6.3

9.1

8.7

31.13

10959

58131

(3021960) Folate [Moles/volume] in Serum or Plasma

6854

31950

1.79

311.71

1.7

1.5

nmol/l

20.1

20.8

2.50

5824

26710

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3893

13241

2.36

307.65

2.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

16205

79007

2.50

307.65

7.2

4.1

mmol/l

6.8

1.44

15501

73501

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2467

5103

3.81

307.65

1.8

1.6

g/l

1.4

1.6

14.57

1994

4338

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7208

18508

3.62

307.65

2.7

1.9

30.8

29.0

79.92

7027

17989

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

393

155

18.79

307.65

9.1

7.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5817

15426

3.31

307.65

3.4

2.2

20.8

23.7

40.68

4974

12986

(3019060) Gas panel - Arterial blood

3001

7436

3.22

307.65

6.7

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2774

7272

3.01

307.65

10.0

6.2

mmol/l

24.6

24.7

0.55

2620

6720

(3022217) INR in Platelet poor plasma by Coagulation assay

6546

12202

4.99

307.65

43.9

9.2

inr

1.9

1.1

105.98

643

2147

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5015

7968

5.53

307.65

3.8

1.9

ng/l

285.9

84.7

112.78

4747

7070

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12732

63722

1.97

307.65

5.0

3.8

—

(3032080) INR in Blood by Coagulation assay

14777

50513

3.91

307.65

20.9

4.3

inr

1.6

1.1

254.67

4289

13694

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13105

62277

2.17

307.65

9.0

5.3

mmol/l

1.2

199.96

11963

55592

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5177

8769

5.21

307.65

2.7

1.9

ug/l

12.7

5.9

55.46

4739

7423

(3022948) Iron [Moles/volume] in Serum or Plasma

6392

18097

3.14

307.65

3.3

2.2

umol/l

11.8

13.5

55.46

5978

16583

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8580

30669

2.61

307.65

2.7

2.1

mg/l

3.3

2.8

49.53

7498

25644

(3006504) Eosinophils/100 leukocytes in Blood

11622

62314

1.69

307.65

7.1

6.0

2.8

2.9

4.30

10863

57535

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14102

68754

2.19

307.65

10.0

5.9

mmol/l

1.2

198.72

11777

57619

(3013512) EKG study

8638

39873

1.90

307.65

6.1

3.2

—

(3001604) Monocytes [#/volume] in Blood

12634

66066

1.83

307.65

6.7

5.8

e9/l

0.6

23.01

11017

56196

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9788

40389

2.29

307.65

2.5

2.0

u/l

238.1

214.0

2.09

9197

37531

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2625

7330

2.81

307.65

9.7

6.5

mmol/l

24.7

0.14

2604

7267

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12278

47220

2.82

307.65

5.2

2.7

ng/l

66.0

59.7

0.22

9838

32596

(3024354) Oxygen [Partial pressure] in Venous blood

2925

9056

2.54

307.65

4.2

3.0

kpa

4.6

0.22

2836

8763

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18387

107937

2.01

307.65

9.2

7.3

u/l

81.2

79.3

4.40

17432

100797

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7383

32815

1.92

307.65

2.9

2.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4844

13495

3.02

307.65

9.6

6.4

kpa

12.4

12.9

4.29

4638

12881

(3020630) Protein [Mass/volume] in Serum or Plasma

3185

10716

2.35

307.65

2.5

2.7

g/l

65.7

67.0

17.41

2910

9672

(3023368) Bacteria identified in Blood by Culture

9116

34950

2.45

307.65

5.6

3.9

—

(3044889) 12 lead EKG panel

17137

97254

1.98

307.65

6.5

3.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6929

22691

2.72

307.65

5.3

2.8

ng/l

1275.8

461.6

7.58

6282

17309

(3024928) Oxygen saturation in Venous blood

1110

2039

4.12

307.65

5.0

2.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3411

10294

2.65

307.65

9.3

6.2

mmol/l

1.3

1.04

3304

9905

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5324

14440

3.17

307.65

3.9

4.5

u/l

268.5

239.3

26.42

5053

13614

(3004119) Hemoglobin [Mass/volume] in Venous blood

2538

6970

2.85

307.65

5.0

2.8

g/l

121.2

129.5

52.08

2461

6825

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1825

4654

3.01

307.65

2.2

1.9

ug/l

1.8

2.3

1.15

1596

4101

(3002032) Base excess in Venous blood by calculation

3547

10887

2.61

307.65

5.2

3.6

mmol/l

1.7

1.8

0.05

2930

8794

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6177

26345

1.95

307.65

2.2

1.6

mg/l

1.3

0.33

4762

20490

(3023520) Reticulocytes [#/volume] in Blood

3774

10611

2.89

307.65

2.9

2.6

e9/l

72.1

67.3

9.98

2924

7981

(3042936) Bacteria identified in Isolate by Culture

4643

18128

2.08

307.65

2.3

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

343

138

18.38

307.65

8.8

8.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5525

19538

2.38

307.65

2.0

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

4971

14091

2.98

307.65

2.7

2.5

1.8

1.7

16.26

4473

12326

(3020779) Urea [Moles/volume] in Serum or Plasma

4284

10146

3.53

307.65

9.5

6.2

mmol/l

11.1

8.9

55.67

4092

9628

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1407

222

49.04

307.65

3.3

2.0

nmol/l

0.8

0.21

1114

100

(3013115) Eosinophils [#/volume] in Blood

12994

68580

1.83

307.65

6.9

6.0

e9/l

0.2

1.36

11445

59186

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6033

16609

3.20

307.65

3.3

2.2

g/l

2.3

0.02

5664

15178

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5869

19634

2.56

307.65

3.9

3.4

mmol/l

0.8

18.87

5497

18129

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3883

13246

2.36

307.65

1.9

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

14061

77654

1.77

307.65

9.5

9.4

e9/l

4.3

4.1

31.45

12360

67202

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4174

11148

3.09

307.65

10.4

7.1

g/l

115.5

122.4

74.61

4059

10713

(42870588) Differential panel, method unspecified - Blood

9336

45859

1.79

307.65

6.6

5.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11094

50177

2.13

307.65

3.7

2.5

ug/l

167.5

148.7

1.68

10190

45676

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2441

6546

2.91

307.65

13.4

8.1

—

(3003396) Base excess in Arterial blood by calculation

4846

13467

3.03

307.65

9.6

6.4

mmol/l

1.2

0.9

3.61

3964

10585

(3000991) Gas panel - Venous blood

3427

9849

2.79

307.65

10.7

7.5

—

(3012544) pH of Venous blood

3859

11251

2.79

307.65

5.4

3.5

7.4

0.11

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14355

70276

2.21

307.65

6.7

6.4

umol/l

13.5

11.4

52.24

13652

66411

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2109

2929

5.66

307.65

4.9

2.6

u/ml

0.3

0.83

1351

1551

(3018418) pH of Serum or Plasma

8441

40341

1.81

307.65

5.4

3.8

7.4

1.92

1878

7351

(3014576) Chloride [Moles/volume] in Serum or Plasma

4900

15666

2.61

307.65

9.0

6.3

mmol/l

104.7

104.4

4.61

4800

15344

(3022096) Basophils/100 leukocytes in Blood

11360

60479

1.70

307.65

7.1

6.1

0.7

3.87

10638

55896

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4756

16207

2.42

307.65

8.2

5.1

mmol/l

1.1

1.0

42.03

4438

15026

(3006315) Basophils [#/volume] in Blood

12703

66415

1.83

307.65

6.7

5.8

e9/l

0.0

2.16

11087

56515

(3016502) Oxygen saturation in Arterial blood

4545

11930

3.19

307.65

9.9

6.8

95.8

96.0

1.13

4403

11495

(3019309) Folate [Moles/volume] in Red Blood Cells

5981

25796

1.92

307.65

1.9

1.7

nmol/l

1260.5

1130.6

18.41

4569

18936

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4849

13503

3.03

307.65

9.6

6.4

kpa

5.1

1.80

4648

12894

(3020891) Body temperature

1794

4572

3.01

307.65

6.2

4.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14914

30078

7.82

307.65

4.4

1.8

ng/l

1875.8

605.8

148.05

13718

24375

(3019198) Lymphocytes [#/volume] in Blood

12827

67977

1.80

307.65

6.8

5.8

e9/l

1.8

2.0

11.35

11341

58916

(3024561) Albumin [Mass/volume] in Serum or Plasma

12218

59388

2.01

307.65

5.9

4.6

g/l

34.4

35.6

88.13

11316

54749

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2873

7454

3.06

307.65

10.8

8.0

1.4

1.3

1.02

2858

7405

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2869

7405

3.07

307.65

11.0

8.1

0.7

4.04

2859

7357

(3014007) Fractional oxyhemoglobin in Arterial blood

2916

7467

3.10

307.65

11.0

8.1

94.0

94.3

1.29

2907

7447

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2162

6290

2.66

307.65

11.8

8.2

mmol/l

24.4

24.2

1.26

2004

5889

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3541

10902

2.60

307.65

5.1

3.6

kpa

5.8

2.27

3444

10596

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1417

3185

3.39

307.65

3.3

2.5

g/l

3.4

3.6

7.46

1366

3053

(3031040) Bacteria [#/volume] in Urine by Automated count

15695

90591

1.75

307.65

5.4

4.2

e6/l

744.1

1522.6

1.54

216

1309

(3044640) Blood type and Crossmatch panel - Blood

9121

43055

1.88

307.65

3.1

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1907

5427

2.70

304.83

5.5

4.1

mmol/l

23.9

24.0

0.47

1671

4890

(3018405) Lactate [Moles/volume] in Arterial blood

1570

4027

2.97

303.22

5.5

3.7

mmol/l

1.3

1.4

0.16

1547

3954

(3013707) Erythrocyte sedimentation rate by Westergren method

17012

102079

1.73

300.24

5.1

3.9

mm/h

15.3

12.1

101.98

15688

93308

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1853

5243

2.71

299.31

3.8

2.5

1.2

1.3

2.11

1845

5214

(3002030) Lymphocytes/100 leukocytes in Blood

11787

64319

1.66

297.79

7.2

6.1

24.7

28.2

188.04

11021

59283

(3018010) Neutrophils/100 leukocytes in Blood

11625

63345

1.65

293.87

6.9

5.9

59.7

56.8

116.52

10883

58690

(3006576) Bicarbonate [Moles/volume] in Blood

386

274

10.43

293.18

8.0

4.9

mmol/l

25.2

24.9

0.54

335

257

(3043409) Potassium [Moles/volume] in Arterial blood

1400

3439

3.09

290.72

5.8

3.9

mmol/l

4.0

3.8

25.20

1330

3244

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

21333

137749

2.09

290.31

24.2

12.4

mg/l

27.6

25.4

18.11

18614

106921

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1809

5149

2.69

288.57

3.7

2.5

0.7

3.26

1751

4898

(3003434) Protein [Mass/volume] in Pleural fluid

756

1239

4.56

276.80

1.6

1.3

g/l

27.9

38.0

69.72

667

1155

(3026008) Bacteria identified in Urine by Culture

8048

40396

1.68

273.56

3.5

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8309

42113

1.67

271.77

3.3

u/l

35.9

34.2

1.08

7906

39681

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

266

106

18.50

270.30

8.1

7.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3459

13465

2.02

267.72

4.3

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8307

42365

1.66

263.18

2.8

2.5

u/l

59.1

59.8

0.42

7632

38640

(3026493) Urate [Moles/volume] in Serum or Plasma

7209

35461

1.69

261.78

3.3

2.5

umol/l

3735.5

5220.4

2.39

6170

30417

(3037467) Urinalysis macro (dipstick) panel - Urine

15874

95478

1.62

250.04

5.2

4.1

—

(3000850) Epithelial cells [#/volume] in Urine

6057

28736

1.72

248.84

3.1

2.5

e6/l

4.7

5.1

1.58

5379

24899

(3027315) Oxygen [Partial pressure] in Blood

1087

2516

3.25

247.94

5.2

3.4

kpa

8.4

8.7

5.61

1066

2455

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10647

58358

1.59

247.10

2.2

1.9

pmol/l

94.8

95.6

0.84

5702

29448

(3033658) Prothrombin time (PT) actual/Normal

6992

34670

1.66

242.46

5.3

3.7

76.1

93.8

307.65

6835

33831

(3004588) Protein electrophoresis panel - Serum or Plasma

2536

9089

2.16

242.34

2.4

—

(3010421) pH of Blood

1180

2926

3.04

240.36

5.1

3.3

7.4

0.08

1050

2447

(3013290) Carbon dioxide [Partial pressure] in Blood

1070

2507

3.21

239.26

5.2

3.4

kpa

5.0

0.63

1049

2447

(3012501) Base excess in Blood by calculation

1069

2507

3.21

238.67

5.2

3.4

mmol/l

2.6

2.4

1.38

742

1687

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1138

2794

3.07

235.63

1.7

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1837

5810

2.41

234.71

4.5

2.9

mmol/l

25.1

25.2

0.23

1781

5651

(3007853) Bacteria identified in Skin by Aerobe culture

3583

14836

1.89

228.96

2.0

1.7

—

(3009343) pH of Capillary blood

2241

7816

2.20

228.40

4.8

3.3

7.4

1.76

372

897

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2262

7922

2.20

228.21

4.8

3.3

kpa

5.1

0.56

2091

7290

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1291

3477

2.81

227.13

4.0

2.1

86.1

91.5

12.24

1235

3231

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2000

6668

2.30

226.79

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2177

7527

2.22

226.53

4.8

3.3

mmol/l

2.1

1.5

8.96

1611

5599

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

16396

100521

1.59

224.21

4.3

3.8

pmol/l

15.3

14.8

75.98

14687

89629

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2439

8863

2.12

224.12

1.8

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

7553

38801

1.61

223.62

3.8

3.0

e6/l

0.5

0.4

3.72

5961

28779

(3023199) Leukocytes [#/volume] in Pleural fluid

655

1139

4.29

222.93

1.6

1.4

e6/l

2488.1

3523.0

0.58

488

842

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

760

1485

3.82

222.21

7.6

5.6

mg/l

12.0

11.6

1.64

698

1372

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2573

9590

2.07

221.14

5.0

3.5

ng/l

114.7

80.9

37.41

2210

8177

(3036489) Thrombin time

1464

4271

2.60

220.92

2.9

2.0

22.9

21.2

11.22

1321

3742

(3002582) Erythrocytes [#/volume] in Urine

8032

42224

1.58

213.55

3.9

3.1

e6/l

110.5

75.7

0.78

6423

31963

(36304419) Bacteria [Presence] in Urine

7273

37394

1.60

212.07

3.7

3.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

19384

124454

1.69

211.93

5.3

4.5

mu/l

2.1

1.05

17557

111570

(40767503) Oxygen content in Capillary blood by calculation

988

2396

3.09

208.48

2.9

2.2

15.7

16.8

10.89

505

1283

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1170

3130

2.82

208.07

3.0

2.5

196.7

191.9

0.98

1122

2971

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1631

5162

2.40

207.28

7.7

4.3

1.7

1.6

3.21

1542

4854

(3018095) Leukocytes [#/volume] in Urine

9026

48978

1.55

207.17

4.4

3.5

e6/l

103.0

101.6

0.04

6838

34373

(3028308) Erythrocytes [#/volume] in Pleural fluid

602

1038

4.31

206.99

1.6

1.4

e6/l

49155.4

58221.2

0.39

373

641

(3012441) Differential panel - Pleural fluid

580

976

4.42

205.44

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1370

4008

2.58

205.24

3.2

3.5

mg/l

45.6

41.9

0.44

1082

3297

(3034860) Kappa light chains.free [Mass/volume] in Serum

1372

4019

2.58

205.00

3.2

3.5

mg/l

56.7

59.0

0.06

1087

3300

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1340

3884

2.61

204.48

3.1

3.4

ratio

10.3

3.4

0.63

325

(3019550) Sodium [Moles/volume] in Serum or Plasma

21912

146323

1.98

202.00

30.9

13.9

mmol/l

139.3

139.7

86.55

21535

141950

(3007930) Methemoglobin/Hemoglobin.total in Blood

1595

5089

2.38

198.91

7.9

4.3

0.9

1.10

1504

4781

(3026782) Osmolality of Urine

5548

27036

1.65

198.62

3.3

2.6

mosm/kgh2o

523.8

563.8

35.86

4767

22768

(1616796) Gas panel - Central venous blood

993

2488

2.99

198.18

4.9

3.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1394

4189

2.52

197.57

2.7

2.1

ug/l

510.4

605.8

0.61

1322

3914

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1663

5422

2.33

197.54

4.9

3.4

49.4

47.1

2.98

1647

5364

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

194

18.53

197.40

7.7

4.2

68.2

58.7

1.08

167

(3035350) Ketones [Presence] in Urine by Test strip

11569

66844

1.50

193.81

4.6

3.5

estimate

0.0

0.25

2417

11968

(3023103) Potassium [Moles/volume] in Serum or Plasma

21920

146757

1.95

193.15

31.1

14.0

mmol/l

4.0

155.61

21519

142115

(3047181) Lactate [Moles/volume] in Blood

1273

3746

2.56

188.14

9.5

5.1

mmol/l

1.3

0.35

1142

3278

(3015736) pH of Urine

9319

51723

1.51

187.07

4.3

3.3

5.8

5.7

—

(3039000) Anion gap in Blood

1010

2667

2.84

183.59

10.3

6.0

mmol/l

10.9

11.2

1.21

932

2399

(3018572) Chloride [Moles/volume] in Blood

1010

2668

2.84

183.46

10.3

6.0

mmol/l

105.3

105.1

0.52

932

2400

(3021589) Normoblasts [#/volume] in Blood

10584

60498

1.49

182.93

13.9

8.9

e9/l

0.0

0.00

8881

49358

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1228

3602

2.57

182.57

1.9

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2658

10701

1.91

181.79

2.9

2.6

ml/min/173m2

56.6

67.0

33.43

1189

4024

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2003

7296

2.09

181.16

1.8

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

762

1738

3.27

177.28

2.0

1.7

mmol/l

1.7

0.16

744

1697

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

505

856

4.38

177.23

1.4

1.3

u/l

250.9

690.2

7.61

477

808

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1004

2699

2.79

176.54

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

11607

68016

1.47

173.78

4.7

3.5

estimate

0.0

0.75

2357

11918

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

978

2620

2.80

173.03

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1353

4282

2.38

171.14

2.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1055

2967

2.67

170.27

3.2

3.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

11458

67239

1.46

168.10

6.0

4.7

estimate

0.0

0.07

2430

12211

(3015377) Calcium [Moles/volume] in Serum or Plasma

8525

47232

1.49

167.15

3.4

3.5

mmol/l

2.3

2.4

23.69

7269

40667

(3045788) Cell count panel - Pleural fluid

495

873

4.20

165.36

1.6

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

6820

36163

1.52

164.44

5.1

3.9

estimate

0.0

0.78

2260

11751

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

889

2333

2.85

163.19

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

544

1048

3.85

161.91

1.6

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

622

1322

3.50

161.07

1.9

1.7

89.3

89.7

0.87

612

1303

(3036782) Glucose [Moles/volume] in Pleural fluid

483

873

4.10

156.38

1.5

1.3

mmol/l

6.8

5.7

12.69

457

790

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1529

5302

2.18

155.92

1.5

1.6

u/ml

14.8

17.4

0.23

160

(40761511) CBC panel - Blood by Automated count

21415

143981

1.74

155.24

24.3

11.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3869

18181

1.66

154.57

10.7

5.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1005

2919

2.58

151.98

3.5

2.7

mmol/l

24.7

24.6

0.01

910

2571

(3028626) Oxygen [Partial pressure] in Capillary blood

956

2755

2.60

146.79

4.5

3.3

kpa

8.1

8.4

4.87

903

2561

(3021901) Oxygen saturation in Capillary blood

787

2050

2.86

146.28

3.3

2.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2879

12670

1.75

145.60

2.3

g/l

0.2

33.46

2637

11825

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5709

29864

1.52

142.85

1.8

1.7

pmol/l

32348276.1

32210524.3

0.01

4600

24275

(40760892) CBC W Ordered Manual Differential panel - Blood

5363

27804

1.52

139.37

5.4

4.5

—

(3012516) Albumin [Mass/volume] in Urine

7799

43620

1.45

138.81

3.5

3.2

mg/l

529.7

379.9

1.74

5148

26813

(40761535) Cells panel - Urine sediment

2580

11159

1.77

138.04

4.2

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

624

1473

3.15

137.21

1.7

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

407

718

4.19

135.90

1.4

1.2

u/l

11.6

15.7

1.84

365

688

(3020682) Albumin/Creatinine [Ratio] in Urine

8134

45999

1.44

135.65

4.3

3.9

mg/mmol

15.0

6.5

28.42

5228

28456

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

907

2682

2.52

132.04

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

745

1993

2.78

131.82

1.6

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2586

11346

1.74

131.29

5.5

3.4

mmol/l

1.2

25.08

2279

9742

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8891

51433

1.41

128.87

5.0

3.7

—

(3022313) Gas panel - Capillary blood

1557

5838

2.01

128.76

5.2

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1810

7167

1.91

127.94

2.0

1.9

g/l

1.2

1.3

1.07

1651

6462

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1064

3441

2.31

127.53

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19585

130224

1.51

127.26

6.9

5.8

mmol/mol

40.6

39.9

20.09

17890

118909

(3023183) Ammonium ion [Moles/volume] in Plasma

853

2516

2.53

124.75

2.9

2.7

umol/l

34.3

34.9

0.26

739

2117

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19757

131757

1.51

124.56

4.8

4.0

mmol/l

1.3

23.27

17925

118339

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

662

1718

2.86

123.75

1.5

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2196

9343

1.79

123.47

2.9

2.8

g/l

10.9

10.5

2.00

2012

8515

(40758558) Short blood count panel - Blood

6257

34152

1.45

123.44

7.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

733

2018

2.70

122.85

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

7928

45397

1.41

119.24

3.4

3.2

mmol/l

6.9

7.7

66.42

6530

37806

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1183

4123

2.15

118.40

1.7

1.6

titre

181.0

256.7

0.77

195

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

593

1520

2.89

113.29

1.5

1.3

—

(3037756) Immunofixation for Serum or Plasma

862

2691

2.39

111.65

1.5

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3116

14967

1.60

110.54

2.9

2.8

umol/l

10.3

9.3

1.31

2707

13070

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1624

6507

1.88

110.19

3.4

3.3

pmol/l

4.3

4.5

14.78

1450

5740

(3037522) Nuclear Ab [Titer] in Serum

3330

16262

1.57

110.07

1.4

1.3

titre

600.4

538.1

0.95

793

3401

(3051593) INR in Capillary blood by Coagulation assay

281

434

4.77

110.03

13.8

3.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1365

5162

1.99

109.77

2.3

g/l

7.2

7.4

2.23

985

3799

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1363

5158

1.98

109.39

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1359

5144

1.98

108.99

2.3

g/l

3.8

0.73

954

3619

(3022493) Free Hemoglobin [Mass/volume] in Plasma

277

430

4.74

107.85

7.9

1.2

mg/l

757.1

2012.0

0.54

220

288

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1288

4806

2.01

107.48

2.3

g/l

10.3

0.07

1060

3966

(40761536) Microorganisms panel - Urine sediment

2445

11142

1.67

106.75

4.9

3.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

21741

149327

1.61

103.20

29.4

14.7

umol/l

89.6

77.0

234.64

21735

149272

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

791

2461

2.39

103.15

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

791

2461

2.39

103.15

1.4

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2407

11049

1.65

101.92

2.2

2.4

nmol/l

381.3

373.0

0.86

2201

10153

(3035880) pH of Pleural fluid

290

496

4.31

100.69

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

501

1249

2.97

100.46

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9295

55734

1.35

100.32

2.5

2.2

nmol/l

78.9

78.7

0.28

8171

49187

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

589

1611

2.71

99.87

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1334

5188

1.93

98.72

5.6

3.6

mmol/l

25.0

24.7

1.65

1231

4779

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1264

4844

1.95

97.62

2.3

g/l

3.2

3.0

7.91

970

3702

(3004451) EKG impression Narrative

265

434

4.49

96.98

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4790

25901

1.44

95.12

2.9

3.2

mmol/l

2.5

0.53

4146

22697

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20172

136805

1.46

95.06

5.4

4.4

mmol/l

1.4

1.5

74.33

18445

123972

(3011397) Hemoglobin [Presence] in Urine by Test strip

5725

31971

1.40

94.77

4.5

3.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20322

138051

1.46

94.50

5.4

4.5

mmol/l

4.3

4.7

307.65

18691

125923

(3019150) Specific gravity of Urine by Refractometry

5296

29204

1.41

94.17

5.3

4.0

kg/l

1.0

1.21

794

4585

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20181

136932

1.45

94.16

5.5

4.7

mmol/l

6.1

6.0

14.71

18132

123360

(3006184) Hemoglobin [Mass/volume] in Capillary blood

838

2793

2.23

93.29

2.7

2.0

g/l

124.3

131.7

11.42

628

1984

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4517

24246

1.44

93.04

3.2

2.7

e6/l

1.2

1.1

0.49

2729

13785

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

384

854

3.32

92.81

1.7

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1256

4922

1.91

90.71

1.9

1.8

u/l

38.6

39.9

1.26

1058

4391

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1154

4396

1.96

90.55

2.5

g/l

0.9

1.0

0.49

979

3727

(44790048)

471

1204

2.89

90.40

1.6

1.5

—

(44790047)

471

1204

2.89

90.40

1.6

1.5

—

(44806118)

471

1204

2.89

90.40

1.6

1.5

—

(44790049)

471

1204

2.89

90.40

1.6

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

351

751

3.45

89.98

1.6

1.4

u/l

14.4

11.8

7.38

336

723

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1315

5255

1.87

89.46

2.0

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21659

149402

1.55

88.97

14.0

10.1

u/l

25.7

26.4

3.13

20825

143031

(3042631) Mycobacterium sp identified in Specimen

598

1757

2.52

88.00

2.4

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

630

1913

2.44

86.53

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

961

3484

2.05

86.44

1.8

1.5

g/l

1.1

1.2

9.01

902

3294

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

939

3385

2.07

85.74

4.7

4.0

mg/l

1.9

1.4

34.06

849

3103

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20645

141218

1.45

85.54

6.1

5.0

mmol/l

2.4

2.8

307.65

18946

128175

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1219

4825

1.89

85.32

1.8

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

932

3368

2.06

84.53

1.8

1.5

g/l

0.2

4.35

874

3166

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

747

2474

2.24

84.37

7.0

5.3

iu/ml

598.6

1303.7

0.53

148

370

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1018

3806

1.99

84.14

2.4

2.3

g/l

0.0

0.35

917

3477

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

723

2373

2.26

83.41

1.3

1.2

titre

71.4

166.1

1.13

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

961

3532

2.03

83.26

2.4

2.3

g/l

0.0

0.12

862

3216

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

946

3481

2.02

81.68

2.4

g/l

0.0

0.00

860

3203

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1055

4036

1.95

81.65

2.3

2.2

g/l

36.7

38.3

15.21

904

3404

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

834

2945

2.10

80.34

2.0

1.8

mg/l

12.5

10.9

2.45

764

2731

(3011648) Oxygen content in Venous blood

344

794

3.19

78.46

2.8

3.0

10.7

10.8

0.25

344

794

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

208

333

4.59

78.26

1.6

1.3

65.8

58.7

1.72

165

288

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

599

1879

2.36

76.63

3.3

2.9

u/ml

2371.3

6436.5

0.42

130

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

913

3405

1.99

75.90

1.6

1.5

iu/ml

18.8

13.3

0.55

(40768797) Stomach Pathology biopsy report

3545

18841

1.44

75.16

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2473

12232

1.53

75.07

1.8

1.5

—

(3003694) ABO and Rh group [Type] in Blood

6270

36735

1.33

72.90

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

713

10175

0.50

72.68

1.3

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

2344

11570

1.53

71.64

4.4

4.0

1.0

0.9

0.12

786

3224

(21494890) Protein electrophoresis panel - 24 hour Urine

451

1289

2.58

70.21

1.9

2.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

239

466

3.77

70.09

40.6

33.2

ug/l

7.3

7.2

0.28

223

421

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

270

579

3.43

69.07

2.1

2.5

89.9

98.9

3.62

262

547

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13338

86728

1.27

67.90

3.6

3.0

u/l

61.5

50.5

26.64

12206

79663

(3021440) Promyelocytes/100 leukocytes in Blood

2228

11002

1.53

67.76

4.4

4.0

0.1

0.11

740

2981

(3002179) Metamyelocytes/100 leukocytes in Blood

2135

10489

1.53

66.41

4.3

3.9

0.7

0.03

595

2324

(3000093) Morphology [Interpretation] in Blood Narrative

423

1207

2.59

66.08

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

585

1954

2.21

64.71

1.2

1.4

u/l

41.3

34.1

0.70

518

1660

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

18.01

64.46

12.3

13.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4194

23491

1.37

64.34

1.6

1.5

g/l

2.7

2.5

4.67

2621

13340

(3025159) Blasts/100 leukocytes in Blood

2101

10355

1.53

64.30

4.4

4.1

0.2

0.3

0.14

647

2522

(3001893) Eosinophils/100 leukocytes in Pleural fluid

173

284

4.47

63.28

1.6

1.3

1.7

3.0

1.65

141

250

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19380

132737

1.33

62.02

22.7

11.9

ml/min/173m2

72.8

79.7

307.65

16939

107443

(3042733) HLA Ab [Presence] in Serum

184

323

4.18

62.01

5.3

4.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

169

279

4.44

61.41

1.5

1.3

mmol/l

2.8

4.4

5.40

155

262

(3000494) Fungus identified in Specimen by Culture

3013

16100

1.42

60.86

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2660

13944

1.44

59.61

1.8

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4005

22547

1.35

58.84

3.4

2.9

e6/l

2.3

2.4

0.15

2232

12183

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9041

56803

1.26

57.80

5.0

5.1

ug/l

2.8

3.5

3.29

7892

51132

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

643

2342

2.03

57.00

1.8

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1558

7374

1.58

56.84

2.6

2.4

—

(3052851) Hemolysis interference index of Serum or Plasma

922

3793

1.80

56.82

4.4

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

592

2096

2.09

56.59

1.8

1.4

u/ml

127.1

108.7

1.29

164

454

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

17.37

56.57

1.2

1.1

ug/l

102.1

123.2

0.20

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

728

2.91

56.51

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

614

2212

2.05

56.06

1.5

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

639

2339

2.02

55.88

1.7

1.4

u/ml

14.6

19.4

0.63

(4010399)

1987

9961

1.50

55.75

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

16843

113792

1.26

55.37

29.5

15.6

14.1

13.6

221.43

16529

111056

(3003181) Sodium [Moles/volume] in Urine

632

2312

2.02

55.36

1.4

mmol/l

61.0

65.1

1.71

515

1841

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

55.16

2.6

0.0

—

(3014891) Appearance of Pleural fluid

7.17

55.09

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

377

1123

2.47

54.00

3.4

2.6

—

(3007461) Platelets [#/volume] in Blood

22092

155141

1.45

53.76

36.6

18.7

e9/l

230.7

249.8

307.65

21624

149858

(3025941) Bacteria identified in Stool by Culture

1414

6628

1.59

53.66

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5901

35458

1.28

53.60

4.3

3.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

140

222

4.62

53.40

1.6

1.3

21.1

22.4

0.18

117

195

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

259

637

2.99

53.32

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

259

639

2.98

53.03

1.6

1.5

—

(3035941) MCH [Entitic mass]

22092

155207

1.44

52.74

36.4

18.6

30.4

1.00

21799

152319

(3010813) Leukocytes [#/volume] in Blood

22096

155260

1.44

52.44

36.6

18.7

e9/l

6.9

6.7

32.45

21556

149383

(3024731) MCV [Entitic volume]

22092

155232

1.44

52.36

36.5

18.6

91.7

91.2

58.60

21798

152331

(3026361) Erythrocytes [#/volume] in Blood

22093

155241

1.44

52.35

36.6

18.7

e12/l

4.3

4.5

307.65

21556

149331

(3034770) Mitochondria Ab [Titer] in Serum

806

3265

1.83

52.20

1.2

titre

870.6

957.7

0.15

101

(3000963) Hemoglobin [Mass/volume] in Blood

22095

155275

1.44

52.08

36.9

18.8

g/l

129.5

136.3

307.65

21807

152370

(3035947) Staphylolysin Ab [Units/volume] in Serum

221

503

3.23

51.70

1.2

1.1

iu/ml

4.9

3.1

1.35

(46235355) HIV 1 and 2 tests - Meaningful Use set

2969

16257

1.38

51.27

1.9

1.7

—

(3037121) Protein [Mass/volume] in Urine

1056

4653

1.69

51.14

3.1

3.4

g/l

0.3

1.13

496

2031

(3020876) Protein [Mass/time] in 24 hour Urine

355

1056

2.47

51.02

2.1

2.0

g/24h

1.0

0.8

0.09

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1047

4624

1.68

50.26

1.2

u/ml

2.1

0.7

1.64

102

420

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

860

3600

1.77

49.97

2.0

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4585

26883

1.30

49.68

1.3

u/ml

2.2

1.9

0.63

1203

6755

(3000919) Neutrophils/100 leukocytes in Pleural fluid

147

260

4.14

49.17

1.5

1.3

20.9

24.6

0.68

129

239

(3007566) Smooth muscle Ab [Titer] in Serum

798

3293

1.79

48.65

1.2

titre

131.9

135.5

0.04

276

(3019225) pH of Specimen

2680

14562

1.39

48.28

5.4

3.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

211

495

3.13

47.06

28.2

28.4

ug/l

106.1

117.1

1.70

163

434

(3023419) Bacteria identified in Sputum by Culture

453

1554

2.15

47.00

2.3

2.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

865

10348

0.60

46.95

1.9

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

100

133

5.51

46.16

1.6

1.3

9.8

11.7

0.30

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

235

602

2.87

45.14

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

235

602

2.87

45.14

1.5

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

18116

124384

1.25

45.06

26.2

13.9

38.0

39.7

85.59

10770

86070

(3040151) Glucose [Moles/volume] in Capillary blood

414

1395

2.19

44.92

6.2

6.5

mmol/l

7.1

7.6

1.73

358

1151

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

525

1945

1.99

44.45

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

836

3597

1.72

44.13

1.5

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

584

2262

1.91

43.48

5.7

2.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

582

2252

1.91

43.46

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

551

2100

1.94

43.03

1.5

1.3

u/ml

292.0

272.0

0.82

374

1282

(40757494) Bilirubin.total [Moles/volume] in Blood

235

620

2.78

42.82

2.2

umol/l

16.2

41.8

1.39

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

470

1704

2.03

42.25

1.3

1.2

u/ml

5.6

3.9

0.66

193

591

(3042010) Triglyceride [Moles/volume] in Pleural fluid

134

5.24

42.20

1.4

1.2

mmol/l

0.5

1.9

2.01

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

148

296

3.66

42.09

1.4

1.2

ug/l

229.9

479.6

0.61

177

(3024891) Influenza virus A+B Ag [Presence] in Specimen

681

2803

1.80

41.87

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

330

1046

2.32

41.39

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

330

1046

2.32

41.39

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

330

1046

2.32

41.39

1.5

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

119

5.47

40.90

1.5

1.3

19.0

28.5

1.54

101

(4094501)

815

3563

1.69

40.59

1.2

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

180

420

3.14

40.57

1.6

2.3

172.9

148.4

2.62

170

396

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.20

40.43

1.3

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

452

1645

2.02

40.23

1.3

1.2

u/ml

5.0

3.7

1.21

217

722

(3016750) Collection duration of Urine

271

798

2.49

39.89

2.4

2.1

min

501.5

497.8

0.22

206

598

(3044927) Protein electrophoresis panel - Urine

380

1301

2.15

39.68

1.2

—

(3000012) Reticulocyte production index

257

740

2.55

39.61

1.5

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

178

4.44

39.48

1.3

1.1

mmol/l

1.2

2.1

9.90

110

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

118

5.27

37.62

12.2

8.5

mmol/l

5.2

5.4

0.25

118

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.17

37.10

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

259

775

2.45

36.90

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

137

285

3.52

36.89

1.3

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

102

5.60

36.68

1.5

1.2

u/l

47.8

385.2

0.70

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

262

791

2.43

36.63

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

255

762

2.46

36.44

2.1

1.7

—

(3019977) pH of Arterial blood

217

602

2.65

36.05

2.8

2.3

7.4

1.31

227

(3049717) Cytology report of Urine Cyto stain

1151

5635

1.52

35.77

2.7

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

355

1234

2.12

35.72

1.6

1.7

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

6.78

35.34

1.3

1.1

mg/l

6.4

9.3

1.14

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2253

12481

1.35

35.30

2.6

2.5

u/l

44.0

52.0

0.43

1935

10661

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

781

3509

1.64

35.07

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

246

738

2.45

34.89

1.2

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

374

1339

2.05

34.85

1.6

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

785

3542

1.64

34.66

1.2

—

(3051651) Icteric interference index of Serum or Plasma

236

698

2.48

34.50

5.8

3.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

786

3553

1.63

34.46

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

532

6636

0.58

33.74

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

104

190

4.01

33.52

2.5

3.6

ml/dl

15.3

14.8

0.88

182

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

297

3.33

33.48

1.4

g/l

15.5

11.3

5.54

109

219

(3033705) Calcium.ionized [Moles/volume] in Venous blood

417

1577

1.95

33.40

3.1

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

679

2981

1.68

33.31

4.3

2.6

mmol/l

1.6

0.38

667

2924

(3012565) Volume of 24 hour Urine

216

627

2.53

32.84

2.4

2.1

1689.8

2030.5

5.42

186

556

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

367

1340

2.01

32.46

1.2

u/l

68.0

69.1

0.04

264

868

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3621

21606

1.26

32.43

1.3

iu/ml

35.6

39.8

0.76

1093

6786

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11174

74357

1.18

32.40

2.6

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

751

3444

1.61

31.09

2.7

2.4

ug/min

134.4

95.3

1.41

453

2011

(3017704) Immunofixation for Urine

224

680

2.42

31.04

1.4

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7086

45488

1.19

30.79

4.5

4.3

22.5

21.7

3.92

3572

22996

(3000492) Spirometry study

2101

11755

1.33

30.60

1.6

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

275

925

2.18

30.13

1.8

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

313

1113

2.07

29.78

2.3

2.4

—

(3038515) Glucose [Moles/volume] in Venous blood

642

2862

1.65

29.75

4.5

2.6

mmol/l

7.4

7.6

0.86

632

2815

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

305

1078

2.08

29.49

1.2

—

(3004775) Volume in Urine collected for unspecified duration

319

1149

2.04

29.33

2.6

2.2

681.1

676.7

0.06

235

772

(3004809) Band form neutrophils/100 leukocytes in Blood

531

2260

1.73

29.21

3.6

3.4

1.4

1.5

0.22

437

1719

(3000475) Leukocytes [#/volume] in Synovial fluid

718

3317

1.60

28.85

1.8

1.6

e6/l

17711.2

12432.0

1.53

539

2382

(4268621)

309

1108

2.05

28.77

2.4

2.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

790

3736

1.56

28.73

1.7

1.6

iu/ml

28.3

7.5

0.57

171

822

(3051611) Lipemic interference index of Serum or Plasma

359

1367

1.93

28.26

5.1

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1489

8003

1.38

28.03

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

430

1747

1.81

27.72

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

688

3181

1.60

27.56

1.4

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

147

386

2.79

27.22

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

593

2.41

26.99

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

593

2.41

26.99

1.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

185

550

2.47

26.87

2.5

2.3

—

(3024471) HLA-A [Type]

144

378

2.79

26.69

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3362

20325

1.24

26.31

1.2

u/ml

13.0

14.3

0.26

1179

7455

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.04

26.28

1.2

1.1

u/l

15.4

25.6

3.24

(3024932) HLA-DR beta [Type]

141

370

2.79

26.16

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

391

2.74

26.09

2.3

1.9

e6/l

27179.9

6776.7

1.00

207

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

141

371

2.78

26.04

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

421

1737

1.78

25.82

1.4

1.3

nmol/l

5.1

1.5

0.58

406

1677

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

652

3024

1.59

25.80

1.3

u/ml

3.5

0.02

309

(3047189) Immunofixation for 24 hour Urine

191

588

2.38

25.77

1.6

1.8

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.78

25.60

1.7

1.3

78.7

71.1

1.00

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

421

1742

1.78

25.58

1.4

1.3

nmol/l

0.2

0.3

0.38

134

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

657

3060

1.58

25.54

1.3

u/ml

10.9

5.8

1.14

130

496

(3011985) Renin [Units/volume] in Plasma

408

1674

1.79

25.50

1.3

1.4

mu/l

79.0

66.3

0.40

359

1490

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

216

706

2.24

25.45

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

460

1965

1.72

25.04

1.5

1.6

g/l

0.8

0.32

321

1477

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

481

2082

1.70

24.96

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

318

1215

1.92

24.85

1.4

g/l

7.6

6.7

2.36

218

841

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

616

2845

1.60

24.82

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

317

1215

1.92

24.55

1.4

g/l

0.5

0.4

1.83

216

836

(3028192) IgG subclass 2 [Mass/volume] in Serum

317

1216

1.91

24.49

1.4

g/l

2.9

0.22

215

841

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.45

24.27

1.3

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

559

2549

1.61

23.76

1.3

1.2

u/ml

3.2

4.8

0.46

189

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

233

810

2.11

23.63

1.6

1.5

u/l

9.0

5.8

0.95

127

369

(3023487) Leukocytes [#/volume] in Peritoneal fluid

157

461

2.49

23.48

2.5

2.0

e6/l

5684.3

4660.1

0.08

118

310

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

371

1520

1.79

23.34

1.4

1.3

nmol/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

689

3314

1.53

23.28

1.3

1.2

u/ml

32.3

42.2

0.51

196

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

405

1705

1.75

23.24

1.5

64.7

56.1

4.30

272

1046

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

124

4.07

22.85

1.1

1.3

nmol/l

6.4

364432.1

1.08

104

(4062490)

310

1209

1.88

22.82

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1359

7436

1.35

22.81

3.3

2.6

e6/l

0.3

0.21

1324

7275

(3010144) Erythrocytes [#/volume] in Synovial fluid

322

1272

1.86

22.79

1.5

1.3

e6/l

176917.1

89786.2

1.12

231

861

(3017569) Oxygen content in Arterial blood

172

535

2.36

22.75

2.3

2.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

318

1256

1.86

22.52

1.6

1.5

24.2

32.2

3.92

204

741

(3033799) Differential panel - Peritoneal fluid

139

393

2.59

22.46

2.4

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

171

3.51

22.19

1.3

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

381

1601

1.75

22.03

1.4

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1311

7173

1.35

22.00

1.3

u/ml

234.5

274.9

0.78

1193

6607

(3021788) Differential panel - Synovial fluid

538

2478

1.60

21.97

1.6

1.5

—

(3016038) Potassium [Moles/volume] in Urine

240

868

2.03

21.97

1.2

mmol/l

34.9

34.4

0.11

207

735

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

213

737

2.12

21.90

1.3

1.2

u/l

109.9

83.5

2.78

191

632

(21494434) Karyotype in Bone marrow

308

1217

1.86

21.81

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

553

2571

1.58

21.72

1.3

1.2

u/ml

9.7

15.2

0.28

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

377

1588

1.74

21.63

1.2

1.3

pmol/l

274.5

289.4

0.24

293

1197

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

207

716

2.12

21.32

1.3

1.2

u/l

29.0

22.3

1.08

182

594

(40768446) Kidney Pathology biopsy report

157

483

2.38

21.31

1.9

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

115

304

2.77

21.15

1.2

93.5

107.0

2.26

104

278

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.50

20.99

2.4

1.8

63.7

54.1

0.87

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

161

3.50

20.78

5.0

5.9

ug/min

59.0

43.7

0.97

125

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

113

299

2.77

20.76

1.1

73.8

88.8

4.35

135

(3044416) Complement C4 [Mass/volume] in Pleural fluid

6.92

20.65

1.1

1.2

g/l

0.1

0.97

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

394

1704

1.70

20.60

1.1

g/l

1.6

1.5

3.24

356

1534

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

185

621

2.18

20.55

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2654

16037

1.23

20.49

3.5

4.4

ug/l

27.4

26.8

0.03

2169

13246

(3014271) Vancomycin [Susceptibility]

196

678

2.12

20.21

3.2

2.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

175

582

2.20

19.91

3.3

4.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

417

4846

0.62

19.86

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

382

1664

1.69

19.48

1.2

1.1

106.4

119.8

10.91

352

1489

(4034850)

838

4352

1.42

19.27

16.4

8.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

169

562

2.20

19.25

2.3

1.8

u/ml

1404.1

1426.3

0.03

164

554

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

305

1255

1.78

19.02

3.6

3.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

793

4089

1.43

18.98

1.4

ug/g

253.9

267.4

1.12

482

2397

(3034426) Prothrombin time (PT)

122

353

2.53

18.91

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

108

294

2.69

18.87

1.1

71.5

91.6

5.00

135

(3039162) Centromere protein B Ab [Units/volume] in Serum

344

1473

1.71

18.70

1.2

u/ml

64.3

59.7

0.13

(3037692) Legionella sp identified in Specimen by Organism specific culture

144

453

2.33

18.68

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

360

1564

1.69

18.56

4.0

3.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

3.12

18.38

4.8

6.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

141

443

2.33

18.35

2.2

1.8

u/ml

43035.0

28908.5

0.12

(3022145) Colonoscopy Study observation

2616

15956

1.22

18.34

1.3

—

(3011412) CD3 cells [#/volume] in Blood

296

1221

1.78

18.33

2.4

2.6

e9/l

1.0

1.2

0.92

183

726

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

187

3.13

18.26

1.2

1.1

77.7

82.1

0.37

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

185

3.12

17.98

1.2

1.1

76.0

71.5

0.38

(3002331) Protein [Mass/volume] in Peritoneal fluid

101

274

2.70

17.79

1.6

1.4

g/l

28.1

28.7

0.04

208

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

245

966

1.86

17.57

1.2

titre

148.7

173.4

0.24

179

(3044242) Glucose [Moles/volume] in Arterial blood

160

542

2.16

17.47

2.2

1.7

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

+∞

17.46

1.4

0.0

umol/l

0.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

244

965

1.85

17.34

1.2

titre

213.6

105.3

0.43

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

634

3191

1.46

17.29

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

314

1342

1.72

17.23

1.3

1.4

mosm/kgh2o

276.2

280.0

1.75

254

1039

(4306422)

380

1709

1.63

17.21

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

332

2.49

17.03

3.0

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

332

2.49

17.03

3.0

2.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.42

16.97

2.2

1.8

8.9

29.9

2.75

(3020961) Endomysium IgA Ab [Titer] in Serum

997

5462

1.35

16.61

1.1

titre

133.5

222.4

1.19

144

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

8.76

16.45

7.3

7.8

43.3

54.0

0.82

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

124

387

2.35

16.44

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

120

370

2.37

16.34

2.7

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

383

1749

1.61

16.34

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

375

1707

1.61

16.21

1.4

—

(3025315) Body weight

4.33

16.19

6.4

3.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.44

16.17

1.1

—

(3002256) Pathology report gross observation

2998

18750

1.19

15.99

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

6.82

15.88

1.3

1.0

ng/l

3203.7

1244.7

1.14

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

379

1739

1.60

15.87

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

369

1683

1.61

15.83

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

373

1708

1.60

15.75

1.4

—

(3010503) CD19 cells [#/volume] in Blood

202

778

1.90

15.63

2.4

2.7

e9/l

0.6

0.4

0.18

194

758

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

368

1688

1.60

15.44

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

235

955

1.80

15.38

2.2

72.6

71.4

0.50

221

915

(3005988) Vibrio sp identified in Specimen by Organism specific culture

368

1691

1.60

15.33

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

252

1050

1.76

15.18

1.7

2.0

mg/l

4.4

3.6

1.66

242

998

(3017732) Neutrophils [#/volume] in Blood

1578

9302

1.25

15.12

3.0

2.9

e9/l

4.4

4.0

3.17

1099

6940

(3045142) Bone marrow Pathology biopsy report

350

1597

1.61

15.02

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

438

2107

1.53

14.95

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

219

879

1.83

14.94

2.3

2.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

230

938

1.80

14.90

2.2

14.4

14.5

0.02

424

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

175

656

1.95

14.69

1.2

1.1

ratio

1.1

0.42

233

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

115

366

2.30

14.65

1.4

pmol/l

15.3

14.8

0.61

307

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

111

352

2.31

14.27

1.1

—

(40768443) Skin Pathology biopsy report

1116

6350

1.30

14.25

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

301

1343

1.64

14.16

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

478

2370

1.48

14.15

1.2

u/ml

46.1

43.5

0.15

221

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.02

14.08

3.5

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

966

5400

1.32

14.06

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

315

1434

1.61

13.70

3.7

3.5

62.4

57.7

2.97

230

895

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5752

38145

1.13

13.68

1.7

1.6

mmol/l

1.3

1.4

2.94

4611

31725

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.65

13.65

1.1

iu/ml

9.8

24.3

0.79

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

163

615

1.94

13.47

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

137

486

2.06

13.43

1.1

u/ml

28.2

5.2

0.61

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

191

2.76

13.34

2.7

3.0

mg/l

54.4

51.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

485

2.05

13.15

2.5

2.9

—

(3016228) CD19 cells/100 cells in Blood

140

508

2.02

12.93

2.2

2.0

9.1

8.6

0.16

134

495

(3013166) Neutrophils/100 leukocytes in Synovial fluid

118

402

2.15

12.85

1.5

1.3

60.9

52.3

1.52

345

(3004616) Nuclear Ab [Presence] in Serum

329

1538

1.57

12.84

1.4

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.68

12.65

6.4

3.1

12.7

14.7

0.16

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

125

3.16

12.65

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

284

1287

1.62

12.62

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

377

1824

1.52

12.61

2.6

1.9

mg/l

22.5

28.8

1.39

481

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

529

2737

1.42

12.57

1.8

iu/l

22.4

11.2

0.26

168

951

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

7.69

12.48

8.3

7.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

439

2204

1.46

12.27

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

392

1924

1.49

12.26

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

231

1000

1.69

12.26

1.6

u/ml

26.0

23.6

0.29

212

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

393

1933

1.49

12.17

1.7

1.9

ug/l

23.2

24.9

0.20

377

1902

(21494814) CD8 cells/100 lymphocytes in Specimen

135

495

2.00

12.15

2.2

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

115

398

2.11

12.07

2.4

2.0

—

(3012898) Urea [Moles/volume] in Urine

103

3.33

12.00

1.2

1.6

mmol/l

156.2

189.4

0.82

(40757373) Influenza virus identified in Isolate

224

2.51

11.99

1.4

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

275

1255

1.61

11.91

1.2

1.1

89.2

97.7

5.31

260

1165

(3034891) Synovial lining cells/100 cells in Synovial fluid

164

648

1.85

11.87

1.6

1.5

2.5

4.1

0.91

124

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

679

1.82

11.62

1.2

1.1

u/l

40.1

23.8

1.11

131

499

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

169

680

1.82

11.56

1.2

1.1

u/l

108.5

81.6

1.91

137

523

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

288

1342

1.57

11.45

1.2

1.1

iu/ml

1.8

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

720

3986

1.33

11.29

4.4

3.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

300

1419

1.55

11.19

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.60

10.98

6.4

6.0

umol/l

396.9

468.1

0.67

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

167

682

1.79

10.92

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

167

682

1.79

10.92

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

167

682

1.79

10.92

1.5

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

213

937

1.66

10.72

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

981

8919

0.79

10.69

1.3

—

(3045716) Anion gap in Serum or Plasma

141

550

1.88

10.67

3.1

2.3

mmol/l

8.9

9.4

0.71

101

400

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

166

683

1.78

10.60

1.5

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

161

2.68

10.47

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

327

1605

1.49

10.32

2.0

2.2

titre

3.9

7.0

—

(3050794) Legionella sp Ab [Presence] in Serum

103

3.12

10.19

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2903

18729

1.15

10.18

5.2

4.6

33.4

32.2

7.33

2040

11899

(3052592) Norovirus Ag [Presence] in Stool

234

2.34

10.14

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.35

10.09

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

298

1443

1.51

10.04

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

2.59

10.03

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

128

2.85

9.98

2.1

—

(4015189)

103

369

2.04

9.97

2.4

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

387

1978

1.43

9.94

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

137

2.77

9.87

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.34

9.81

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

337

2.08

9.81

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

367

1867

1.44

9.68

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

117

444

1.93

9.66

1.2

—

(40768804) Tissue Pathology biopsy report

8315

57080

1.10

9.61

2.2

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1962

16509

0.86

9.40

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

123

482

1.87

9.25

1.1

90.6

98.3

1.48

104

382

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

131

2.73

9.08

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

197

2.37

8.96

2.2

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

621

1.74

8.93

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

235

1111

1.55

8.90

2.2

2.3

40.0

37.9

0.19

136

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

116

453

1.87

8.84

2.8

2.1

—

(3000330) Specific gravity of Urine by Test strip

1206

7321

1.21

8.82

4.2

3.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

172

2.46

8.80

1.7

2.0

—

(3006270) Folate [Moles/volume] in Blood

235

1117

1.54

8.70

1.2

1.1

nmol/l

315.2

349.4

1.85

199

916

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

670

1.70

8.68

3.5

3.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

113

441

1.87

8.64

2.5

1.4

ug/l

22.9

551.4

1.42

106

414

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

194

884

1.61

8.61

2.2

2.7

e6/l

414.5

581.6

2.73

159

746

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

183

823

1.63

8.56

1.3

titre

121.9

60.8

0.35

(3048879) Bone marrow aspiration report

106

407

1.90

8.52

1.4

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

555

1.77

8.48

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

555

1.77

8.48

1.6

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

187

850

1.61

8.39

1.3

titre

227.3

445.5

0.67

(3003338) MCHC [Mass/volume]

16334

115812

1.09

8.38

32.8

16.5

g/l

330.8

332.8

148.67

16184

114921

(3036670) Protein [Mass/volume] in Synovial fluid

108

420

1.88

8.36

1.2

1.3

g/l

39.3

39.5

0.04

221

(21491868) Cryoglobulin [Mass/volume] in Serum

105

407

1.89

8.22

1.2

g/l

0.6

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

366

1.94

8.22

2.2

2.0

u/l

43.5

35.8

0.15

332

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

561

1.75

8.19

1.6

2.0

—

(3005570) Glucose [Moles/volume] in Urine

274

1364

1.47

8.17

2.1

1.8

—

6.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

363

1.93

8.09

1.8

1.6

ug/l

10.1

9.2

1.10

363

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

440

4268

0.75

8.05

2.0

1.4

mg/l

4.2

3.5

0.53

305

2964

(3028300) Cannabinoids [Presence] in Urine

293

3030

0.70

8.05

2.7

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

290

3003

0.70

8.03

2.5

2.0

—

(3027008) Opiates [Presence] in Urine

293

3024

0.70

7.96

2.5

2.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

181

828

1.60

7.94

1.4

umol/l

15.0

12.4

4.07

176

782

(3039443) Prostate specific Ag panel - Serum or Plasma

310

3166

0.71

7.92

1.5

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

2309

14916

1.14

7.90

2.1

2.3

ug/g

155.5

141.0

1.02

1805

11579

(3027944) Amphetamines [Presence] in Urine

286

2958

0.70

7.87

2.2

2.0

—

(3036603) Volume of Urine

188

872

1.58

7.80

1.7

1.6

1781.2

2051.8

1.55

204

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

239

2.14

7.77

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

319

1652

1.41

7.74

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

122

506

1.76

7.73

1.5

1.7

nmol/l

5.2

9.9

0.43

105

417

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

182

845

1.58

7.54

2.4

2.8

e9/l

0.2

3.06

160

741

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

211

1016

1.52

7.44

1.3

1.2

u/ml

15.4

40.5

2.88

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

210

1013

1.52

7.35

1.3

1.2

u/ml

45.9

84.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

256

1287

1.46

7.32

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

688

4028

1.25

7.16

1.6

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

214

1044

1.50

7.12

1.3

1.2

u/ml

35.4

53.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

201

969

1.52

7.07

1.3

1.2

u/ml

13.5

5.5

0.39

(3016879) Cocaine [Presence] in Urine

276

2815

0.71

7.05

2.6

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

911

5512

1.21

6.97

2.9

3.6

u/ml

562.5

1360.4

1.71

752

4768

(40761539) Cells [Type] in Urine sediment by Light microscopy

336

1.89

6.96

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

169

2.29

6.96

1.2

1.3

ng/l

100.6

152.2

0.48

116

(3033923) Metanephrine [Moles/time] in 24 hour Urine

236

2.07

6.92

1.2

1.1

umol/24h

0.6

0.7

0.04

103

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

939

8186

0.83

6.88

1.8

1.9

—

(3046861) Legionella sp Ag [Presence] in Urine

3.20

6.83

1.1

—

(3003129) Base excess in Capillary blood by calculation

354

1.86

6.82

2.1

1.6

mmol/l

1.9

0.3

2.69

337

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

161

746

1.58

6.78

2.6

2.9

39.0

37.4

0.30

238

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

783

4684

1.23

6.71

1.7

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

254

2.01

6.70

2.4

2.5

mmol/l

7.9

7.6

0.16

151

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

202

987

1.50

6.70

2.2

2.6

e6/l

527.2

770.8

1.20

391

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

565

3262

1.27

6.65

2.9

3.5

u/ml

1665.6

793.6

0.36

513

2966

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

227

2.06

6.52

1.5

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

344

1.85

6.51

2.4

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

288

1.93

6.46

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

363

1.81

6.34

1.5

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1411

8950

1.16

6.27

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

242

1.99

6.18

1.1

pmol/l

3.6

9.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

224

2.02

6.05

1.6

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

444

1.70

5.82

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.88

5.81

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

153

728

1.54

5.81

1.7

1.9

u/field

1.4

2.9

2.34

105

501

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4861

33189

1.09

5.81

3.1

ug/l

0.8

0.22

3448

22512

(3006922) Hepatitis E virus Ab [Presence] in Serum

171

837

1.49

5.70

1.1

—

(3045414) Leukocytes [Presence] in Urine

982

6102

1.18

5.68

2.1

1.8

—

(4024509)

252

1329

1.39

5.64

1.7

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

226

1.97

5.59

1.3

1.4

titre

163.0

154.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

243

1277

1.39

5.56

1.3

—

(4146454)

318

1747

1.33

5.50

2.8

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

218

1.98

5.45

4.5

2.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1126

0.61

5.28

1.3

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

358

2015

1.30

5.24

2.6

u/ml

246.8

1054.9

1.29

350

1972

(1001926) Buprenorphine [Presence] in Urine by Screen method

233

2318

0.73

5.22

2.5

2.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

13.14

5.22

1.0

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

416

3826

0.79

5.20

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

269

1.85

5.17

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

6052

46562

0.93

5.17

3.5

2.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

339

1.75

5.13

1.1

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

183

932

1.44

5.04

1.1

mg/l

304.3

282.5

3.28

165

838

(3018291) Platelet Ab [Presence] in Serum

4.87

5.01

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

104

2.39

4.99

1.4

ml/s/173m2

0.7

1.3

2.19

(3043238) Trisomy 21 risk [Likelihood] in Fetus

881

0.58

4.97

1.4

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

803

1.47

4.95

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

138

667

1.51

4.95

4.3

3.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.30

4.94

1.0

mmol/l

5.6

5.4

0.12

(3001964) Herpes simplex virus Ag [Presence] in Specimen

366

1.70

4.90

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

495

1.59

4.89

1.1

miu/ml

1608.7

1544.8

0.24

108

495

(3037556) Urate [Mass/volume] in Serum or Plasma

389

1.67

4.86

1.7

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

235

2306

0.74

4.84

3.5

3.7

u/ml

38.7

44.7

0.19

222

2248

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

208

1095

1.39

4.78

1.9

2.0

u/field

2.0

2.5

0.28

426

(3002621) Streptococcal DNAse B [Units/volume] in Serum

111

2.30

4.76

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

116

545

1.56

4.74

1.3

1.6

umol/l

20.0

26.8

1.72

108

520

(3019174) dRVVT (LA screen)

2.46

4.71

1.1

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.45

4.70

2.8

3.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

856

0.59

4.67

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

1082

0.63

4.66

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

149

743

1.47

4.62

1.4

1.3

nmol/l

1.2

0.04

118

568

(3005033) Fetal Nuchal fold Thickness US

853

0.59

4.61

1.4

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

+∞

4.59

1.2

0.0

ug/l

184.4

—

(4211845)

148

738

1.47

4.59

4.1

3.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

798

1.45

4.59

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

874

7392

0.86

4.57

1.7

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

133

651

1.49

4.53

2.2

ug/min

99.5

123.0

0.16

150

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

384

3494

0.80

4.44

1.4

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

152

768

1.45

4.43

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

107

1182

0.66

4.40

1.4

1.3

pmol/l

67.0

96.5

0.55

374

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1040

0.64

4.39

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1039

0.64

4.37

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1039

0.64

4.37

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

152

770

1.44

4.37

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1035

0.64

4.31

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

169

878

1.41

4.25

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

168

872

1.41

4.25

1.1

—

(3011288) Drugs identified in Urine by Screen method

198

1950

0.74

4.24

4.0

3.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.33

4.23

1.1

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

653

0.56

4.15

12.6

12.2

mmol/l

0.6

0.10

593

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

257

1.76

4.14

1.1

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

345

1.65

4.13

1.4

1.2

30.3

40.0

1.53

228

(3023420) DNA double strand Ab [Units/volume] in Serum

227

1246

1.33

4.08

1.7

1.4

iu/ml

27.1

23.7

0.25

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

167

873

1.40

4.07

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

161

840

1.40

3.98

1.6

1.4

umol/l

78.4

71.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

167

878

1.39

3.95

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

427

2547

1.23

3.95

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

464

1.54

3.95

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

166

872

1.39

3.95

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

335

3048

0.80

3.92

1.8

1.9

—

(36660697) Celiac disease serology panel - Serum

1510

9937

1.12

3.91

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

317

1.66

3.91

1.1

1.2

pmol/l

401.8

252.2

1.10

232

(40768800) Prostate Pathology biopsy report

454

4001

0.82

3.90

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.54

3.90

1.3

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

125

1306

0.70

3.89

1.1

u/ml

1.9

4.3

2.79

516

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

146

753

1.42

3.86

1.8

1.4

u/l

7.3

5.9

0.49

118

630

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

516

3144

1.20

3.86

1.1

u/ml

9.8

7.6

0.27

346

(3006245) CD3-CD19+ cells/100 cells in Blood

467

1.53

3.85

2.4

2.5

10.4

11.0

0.16

430

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

166

878

1.38

3.81

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

364

2144

1.24

3.80

1.5

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

138

707

1.43

3.80

1.3

1.2

u/l

236.1

398.4

1.53

129

659

(3024263) Appearance of Synovial fluid

138

709

1.42

3.75

1.6

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

512

1.50

3.72

1.7

2.0

umol/l

78.6

136.4

2.82

273

(42529582) MDA5 Ab [Presence] in Serum by Line blot

311

1.64

3.69

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

311

1.64

3.69

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

311

1.64

3.69

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

311

1.64

3.69

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

186

1.85

3.68

1.4

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

509

3121

1.19

3.59

1.2

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.47

3.54

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

188

1028

1.34

3.53

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

584

0.57

3.51

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

214

2024

0.77

3.51

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

530

3269

1.19

3.50

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

408

1.54

3.48

2.4

3.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

467

1.50

3.47

2.2

2.3

29.6

29.3

0.08

440

(3010838) Calcium [Moles/time] in 24 hour Urine

134

698

1.40

3.41

1.6

1.7

mmol/24h

6.4

5.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

161

1576

0.74

3.40

1.0

1.1

u/ml

1.9

2.1

0.08

386

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1136

7420

1.12

3.40

1.2

iu/ml

117.2

142.6

1.35

377

2717

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

107

535

1.46

3.39

2.1

2.4

umol/l

53.1

53.7

0.06

441

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.23

3.39

3.5

2.9

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.31

3.36

1.0

1.1

u/field

1.0

1.1

0.31

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.85

3.35

1.0

1.2

u/field

1.0

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

171

1.84

3.35

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

126

1275

0.72

3.31

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

112

568

1.44

3.31

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

270

1.65

3.30

1.7

2.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

117

599

1.43

3.29

1.7

1.5

ug/l

8.6

8.3

0.09

104

542

(3045424) Erythrocytes [Presence] in Urine

393

2377

1.21

3.25

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.30

3.21

1.8

1.7

mg/l

1.7

1.1

0.24

(40765096) Chromosome analysis panel by Banding

424

1.50

3.15

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

121

1220

0.72

3.13

1.1

u/ml

2.9

4.8

1.03

487

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

105

1083

0.71

3.12

1.0

u/ml

0.2

0.6

1.15

284

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

321

1.57

3.09

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

104

2.04

3.05

1.1

1.2

umol/24h

1.7

1.6

0.09

104

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

297

1761

1.23

3.01

3.7

3.4

nmol/l

16.0

8.9

0.67

284

1721

(3008116) Ketones [Moles/volume] in Urine by Test strip

261

1.62

2.98

1.4

1.3

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

4.1

0.00

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

2.7

3.7

0.33

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

5.0

2.3

0.65

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

1.7

0.00

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

0.7

1.4

0.46

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

2.3

0.8

0.46

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

1.6

1.8

0.08

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

1.7

1.8

0.04

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.26

2.98

1.8

1.7

mg/l

0.8

1.7

1.00

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

141

761

1.35

2.95

1.1

nmol/l

10.5

7.2

0.24

146

(3023323) Follitropin [Units/volume] in Serum or Plasma

387

3362

0.84

2.95

1.4

iu/l

29.5

30.9

0.33

322

2812

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2054

13921

1.08

2.93

1.5

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

450

1.46

2.91

1.7

1.4

iu/ml

2427400.0

1016240.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

543

3417

1.16

2.89

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

185

1045

1.29

2.84

2.0

1.9

ug/l

4.0

3.3

0.50

165

912

(3025130) Human papilloma virus identified in Specimen

123

1214

0.74

2.82

1.5

1.7

—

(3025577) Chromium [Mass/volume] in Blood

179

1008

1.30

2.82

2.1

2.0

ug/l

2.4

2.3

0.14

155

830

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

806

5223

1.13

2.81

1.1

u/ml

11.9

2.9

0.42

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.15

2.80

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

359

1.51

2.79

1.8

1.5

ug/l

0.4

0.22

228

(3023410) Appearance of Cerebral spinal fluid

144

1386

0.76

2.78

1.7

1.8

—

(3020491) Glucose [Moles/volume] in Blood

172

968

1.30

2.73

1.6

1.9

mmol/l

7.2

6.9

0.59

116

674

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

245

1.61

2.72

1.2

mg/l

135.7

35.1

0.46

195

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

189

1080

1.28

2.68

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

950

0.71

2.67

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

115

1.90

2.67

2.7

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

180

1.70

2.63

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

447

0.59

2.62

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

456

0.59

2.62

2.6

2.5

nmol/l

158.8

150.2

0.11

389

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.55

2.61

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

313

1.52

2.56

1.1

—

(1002224) Polysomnography panel

582

4838

0.87

2.56

1.1

—

(40768441) Liver Pathology biopsy report

183

1049

1.28

2.55

1.4

1.3

—

(44813793)

151

847

1.30

2.49

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

334

2049

1.19

2.47

1.5

1.6

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.89

2.39

1.8

3.6

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.74

2.39

1.1

1.0

g/l

0.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.87

2.36

1.5

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

192

1.64

2.35

1.6

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

292

0.52

2.32

2.5

3.0

ng/l

195.8

114.5

0.61

132

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

148

839

1.29

2.29

1.4

1.3

u/ml

1.7

1.3

0.19

409

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.87

2.24

1.0

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

111

607

1.34

2.23

1.4

1.2

58.4

64.2

0.24

(3015076) Soybean IgE Ab [Units/volume] in Serum

531

0.66

2.19

1.1

u/ml

0.4

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.93

2.17

1.4

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

202

1201

1.23

2.12

1.3

nmol/l

1.4

0.25

180

1090

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

126

1183

0.78

2.11

1.0

ng/l

327.7

333.5

0.09

824

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

170

993

1.25

2.09

2.3

2.5

nmol/l

17.1

17.5

0.25

161

948

(40768793) Breast Pathology biopsy report

344

2918

0.86

2.08

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

345

0.59

2.06

1.4

2.4

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.50

2.05

1.2

1.1

g/l

0.0

0.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

259

1.49

2.02

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

111

1.78

2.01

1.6

1.7

umol/l

50.1

42.7

0.47

111

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

230

1.52

2.01

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

851

0.75

1.99

1.8

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

850

0.75

1.98

1.6

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.86

1.95

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.86

1.95

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

178

1056

1.23

1.94

1.4

promille

1.1

1.4

1.52

124

822

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.07

1.93

6.0

1.4

mu/l

2.9

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

929

0.76

1.92

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

202

1779

0.83

1.92

1.0

1.1

u/ml

5.5

4.3

0.39

918

(3000060) B lymphocytes [#/volume] in Blood

347

1.41

1.92

2.4

e6/l

142.9

1078.2

0.83

201

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

1190

0.79

1.91

1.0

ng/l

43.7

42.6

0.11

818

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

498

4089

0.89

1.90

1.8

1.7

nmol/l

45.7

42.3

2.45

478

3962

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.22

1.89

1.1

pmol/l

197.4

190.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

1187

0.79

1.87

1.0

ng/l

747.9

727.4

0.17

795

(3008401) Mugwort IgE Ab [Units/volume] in Serum

196

1724

0.83

1.86

1.0

1.1

u/ml

1.0

1.1

0.08

769

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

577

3775

1.12

1.84

1.9

1.7

—

(40768795) Lymph node Pathology biopsy report

233

1428

1.19

1.84

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

706

0.73

1.84

1.4

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

124

0.41

1.82

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

982

6606

1.09

1.79

1.7

1.6

—

(3022621) pH of Urine by Test strip

1346

9169

1.08

1.79

3.5

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

252

2160

0.85

1.79

1.1

iu/ml

81.6

5472.2

0.56

446

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

229

1978

0.84

1.78

1.1

u/ml

2.3

1.3

0.44

833

(3034274) Bile acid [Moles/volume] in Serum --fasting

146

857

1.24

1.78

1.7

2.1

umol/l

13.5

10.5

0.32

106

626

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1223

8311

1.08

1.75

1.3

au/ml

68.5

54.3

0.70

373

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.78

1.73

1.1

1.0

titre

2880.0

1841.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

167

999

1.22

1.72

1.2

mmol/l

11.5

12.2

0.42

298

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.85

1.71

5.9

5.2

—

(3018133) Calcium [Moles/volume] in Urine

234

1.47

1.69

1.9

2.2

mmol/l

2.5

2.6

0.19

208

(44806420)

420

1.34

1.66

2.2

2.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

190

1655

0.84

1.66

1.1

1.2

mmol/l

7.5

0.09

138

1176

(3028707) Methadone [Presence] in Urine by Screen method

148

1320

0.82

1.65

2.9

2.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

573

1.29

1.65

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.65

1.65

1.3

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1343

9183

1.07

1.64

2.5

2.4

au/ml

35.5

27.1

0.76

455

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.73

1.62

1.5

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

165

0.49

1.61

2.8

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

313

0.63

1.61

4.2

6.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.95

1.59

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.54

1.56

1.0

—

(3000285) Sodium [Moles/volume] in Blood

167

1.53

1.55

1.4

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

660

0.75

1.55

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

106

0.41

1.55

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

320

1.37

1.51

1.1

1.2

—

818.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.00

1.51

12.2

8.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

105

1.67

1.50

4.5

6.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

739

1.24

1.48

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

178

0.53

1.46

4.8

2.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.32

1.45

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

177

0.54

1.44

9.5

5.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

367

1.33

1.44

1.2

1.3

nmol/l

103.4

127.3

1.18

248

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.82

1.43

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

159

1.52

1.42

1.4

1.3

mmol/l

6.0

6.2

0.09

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

708

0.77

1.42

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

369

2399

1.12

1.40

1.3

miu/ml

158.0

210.8

2.04

116

1005

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

269

1.38

1.39

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.93

1.38

1.0

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.37

0.0

2.7

—

30.7

—

(3049242) von Willebrand panel - Platelet poor plasma

2.11

1.36

1.9

1.5

—

(4035726)

1930

13435

1.05

1.34

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

340

1.33

1.34

2.1

2.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

404

1.30

1.33

1.3

1.2

34.8

17.4

0.95

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

162

1.49

1.32

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

168

1.48

1.32

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.89

1.32

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

180

1119

1.18

1.30

1.4

u/l

32.9

29.0

0.72

145

921

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

180

0.57

1.30

1.2

1.1

u/ml

42.5

67.3

1.34

173

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

226

1431

1.15

1.30

1.7

1.9

titre

840.0

2610.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

151

1.50

1.29

3.3

2.7

mg/l

0.9

1.3

1.07

107

(37021550) Renin [Units/volume] in Plasma --upright

292

1.35

1.29

1.1

1.2

mu/l

97.6

56.7

0.74

219

(3001186) Copper [Moles/volume] in Serum or Plasma

305

1.34

1.28

1.2

umol/l

17.9

16.6

1.53

273

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

195

1.42

1.24

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

362

2937

0.90

1.23

1.9

1.7

mu/l

322.1

293.8

0.83

327

2692

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.67

1.23

1.2

1.5

pmol/l

12.8

17.9

0.78

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

159

1.47

1.23

2.4

2.9

u/field

0.7

0.5

0.37

159

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

335

0.70

1.22

1.9

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

262

1687

1.13

1.20

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

445

1.26

1.17

1.3

umol/l

2.7

3.8

3.43

409

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1922

14627

0.96

1.14

1.7

1.8

1.6

1.5

6.19

1611

12666

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.03

1.14

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

275

1.33

1.11

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

344

0.72

1.09

1.4

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.76

1.09

1.1

1.5

—

(3009992) Blasts/100 cells in Bone marrow

2.43

1.08

1.8

1.5

17.6

13.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

614

0.80

1.07

1.1

u/ml

3.1

6.9

0.37

173

(4212803)

128

1.48

1.07

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

166

1048

1.16

1.05

1.4

1.3

mmol/l

2.3

2.1

0.60

151

977

(3007463) Buprenorphine [Presence] in Urine

2.13

1.04

13.1

7.3

—

(3024869) Neuronal Ab [Presence] in Serum

278

1.31

1.04

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

358

2873

0.91

1.04

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

150

941

1.16

1.03

2.8

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.60

1.03

1.1

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.93

1.02

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

139

0.58

1.00

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

179

1.39

1.00

1.4

1.6

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

1.00

0.0

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.8

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

345

1.27

0.99

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

269

0.70

0.98

1.4

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

101

1.52

0.97

1.1

u/l

9.0

9.9

0.12

101

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

162

1029

1.15

0.96

1.8

1.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

146

0.60

0.96

16.2

1.4

mmol/l

8.1

7.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

146

0.60

0.96

2.7

2.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

578

1.20

0.95

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.75

0.94

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

349

1.26

0.92

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.47

0.90

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

146

1.40

0.89

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

635

0.83

0.85

1.1

u/ml

0.7

2.4

1.70

210

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.59

0.85

1.1

1.4

—

(3002619) Bacteria identified in Specimen by Culture

282

1.27

0.84

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

288

1916

1.10

0.82

1.4

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

381

1.23

0.82

1.2

1.7

—

616.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.80

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.72

0.80

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

590

0.83

0.79

1.4

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

120

0.61

0.79

1.0

—

(40762814) Titanium [Mass/volume] in Blood

298

1.25

0.78

2.5

2.3

ug/l

3.0

3.5

0.62

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

898

6238

1.05

0.78

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

247

0.74

0.76

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

112

709

1.15

0.75

1.2

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

190

1.31

0.74

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.55

0.73

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.82

0.73

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

107

897

0.87

0.72

1.4

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.64

0.71

1.0

1.2

nmol/l

207.4

325.6

1.53

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

103

1.42

0.71

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

824

6306

0.95

0.71

3.0

4.0

u/ml

45.3

63.2

1.62

777

6093

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.44

0.70

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

408

3187

0.93

0.70

4.7

3.1

mg/l

29.1

27.7

0.34

276

1948

(4133840)

356

1.21

0.70

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.56

0.70

1.2

1.4

nmol/l

420.9

593.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

203

1342

1.10

0.70

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

115

736

1.14

0.68

1.1

—

(4281824)

225

1498

1.10

0.68

1.3

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.66

0.68

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.67

3.9

5.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

427

2920

1.07

0.67

1.7

nmol/l

0.9

0.8

2.89

357

2440

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

282

0.78

0.66

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

538

0.84

0.66

1.8

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

264

1776

1.09

0.64

1.1

au/ml

10.4

12.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

1.30

0.64

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.57

0.62

3.7

4.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

102

653

1.14

0.62

3.0

3.1

mu/l

31.8

25.9

0.45

615

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

190

1.27

0.61

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

190

1.27

0.61

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

244

1642

1.09

0.60

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

594

1.14

0.59

1.2

1.1

ng/l

862.7

736.8

0.07

142

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.62

0.59

1.4

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.54

0.58

1.7

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

172

1.27

0.58

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

1.35

0.57

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

205

1.25

0.57

1.7

1.8

pmol/l

85.9

50.6

0.46

169

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

458

0.84

0.57

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

193

0.76

0.56

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

1951

0.93

0.56

4.0

5.0

umol/l

360.3

361.7

0.06

219

1654

(3016018) Differential panel - Cerebral spinal fluid

192

1521

0.92

0.53

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

787

0.89

0.52

1.3

g/l

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.51

0.51

1.0

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

134

886

1.10

0.51

2.0

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

302

1.18

0.51

1.1

u/ml

0.8

5.8

1.06

167

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.49

0.51

3.9

4.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

216

1.22

0.49

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.55

0.49

5.0

5.9

—

(3003577) Lead [Moles/volume] in Blood

1.36

0.48

1.1

1.3

umol/l

0.1

0.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

774

0.90

0.48

1.5

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

398

3055

0.95

0.45

1.5

1.6

e6/l

2646.4

1990.7

0.18

341

2483

(3009677) Dengue virus Ab [Presence] in Serum

1.42

0.45

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

444

3088

1.05

0.45

2.5

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1579

11805

0.97

0.45

2.1

nmol/l

12.2

12.8

2.24

1340

10449

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

407

0.86

0.44

1.3

1.2

g/l

0.3

0.81

328

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

631

0.89

0.44

1.3

1.6

ug/l

2.9

5.5

2.03

484

(3012989) Citrate [Moles/time] in 24 hour Urine

1.66

0.44

1.2

1.3

mmol/24h

1.3

2.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

398

3049

0.95

0.43

1.5

e6/l

56.7

27.2

0.45

326

2364

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.33

0.43

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

444

0.87

0.42

1.4

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.42

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.34

0.41

1.1

u/l

55.9

160.3

0.60

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.43

0.40

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.40

0.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

761

1.09

0.40

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

552

1.11

0.39

1.0

1.1

u/ml

4.3

8.5

1.09

(43055514) Macroprolactin [Presence] in Serum or Plasma

182

1.20

0.39

2.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

0.69

0.37

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

395

1.13

0.37

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

284

1968

1.05

0.36

2.1

2.2

u/l

3231.0

4448.4

0.32

719

(3042517) Benzodiazepines panel - Urine

1.31

0.36

3.9

2.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.29

0.34

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

118

1.24

0.34

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

202

0.83

0.34

1.6

2.1

umol/l

15.5

17.6

0.49

202

(3032352) Blasts [#/volume] in Cerebral spinal fluid

178

0.82

0.33

2.0

2.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

178

0.82

0.33

1.7

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

295

1.14

0.33

1.5

1.8

au/ml

185.5

115.9

—

(3006598) pH of Arterial cord blood

0.68

0.33

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

378

1.12

0.33

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

379

0.89

0.32

1.2

108.8

112.5

0.43

336

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

121

821

1.08

0.31

6.1

6.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

341

2592

0.96

0.31

1.4

pmol/l

130.4

176.1

1.95

332

2529

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

332

1.12

0.31

1.5

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

675

0.92

0.30

1.0

—

(4027681)

690

0.92

0.30

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

360

1.12

0.30

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

291

1.13

0.30

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

521

1.09

0.30

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

315

0.88

0.29

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.32

0.29

1.5

1.3

—

(3001729) Color of Synovial fluid

114

1.22

0.29

1.7

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.25

0.29

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

175

1.17

0.29

1.7

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

182

1.16

0.29

9.1

8.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

143

0.82

0.29

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.30

0.28

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

1.17

0.28

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.75

0.28

1.6

1.3

umol/24h

251.2

358.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

389

0.90

0.27

1.3

1.5

mmol/l

8.4

8.2

0.08

227

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.29

0.27

1.4

u/field

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

357

1.10

0.26

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.22

0.24

1.1

1.6

17.0

10.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

172

1.15

0.23

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

468

3511

0.97

0.23

1.4

mg/l

570.5

555.0

0.24

447

3335

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

147

0.84

0.23

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

123

949

0.95

0.23

1.1

mg/l

47.1

44.8

0.17

807

(40758358) Immune stain study

0.75

0.23

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

118

911

0.94

0.22

1.1

mg/l

305.6

298.2

0.11

102

806

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

111

764

1.06

0.22

1.0

1.1

iu/ml

13.9

9.6

0.82

164

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.22

0.0

1.0

—

26.1

—

(3008898) HLA-B27 [Presence]

470

3520

0.97

0.21

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

261

0.89

0.21

1.7

1.9

ug/l

2.1

2.6

0.53

151

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

160

1.14

0.21

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

420

2984

1.03

0.21

1.5

1.4

u/l

12.3

9.7

2.88

337

2387

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.26

0.20

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

199

1510

0.96

0.20

1.1

u/ml

2.7

3.5

0.52

614

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

182

1.12

0.19

2.0

1.5

nmol/l

0.2

0.25

123

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

105

0.83

0.19

1.2

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

155

1.13

0.18

1.6

2.5

mmol/l

1.1

1.6

0.58

108

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.22

0.18

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

176

1.12

0.18

1.7

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

211

1.11

0.18

1.0

—

(3013862) HLA-DP [Type]

0.74

0.17

1.0

—

(40758292) HTLV I+II Ab panel - Serum

226

1.10

0.17

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

393

2929

0.98

0.15

2.0

1.9

pmol/l

188.0

202.1

2.25

368

2758

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

249

1.08

0.15

1.0

u/ml

15.6

12.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

367

0.93

0.14

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.83

0.14

1.1

1.5

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.83

0.14

1.3

1.2

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

193

1368

1.03

0.13

3.2

3.0

mg/l

61.0

38.4

0.71

143

973

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

300

1.07

0.13

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

117

1.12

0.13

1.1

u/ml

0.0

0.2

0.56

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

223

1.08

0.12

1.1

1.4

53.1

53.6

0.02

(3003740) Influenza virus B Ag [Presence] in Specimen

205

1535

0.97

0.12

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

695

1.04

0.12

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.16

0.11

1.1

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

205

1533

0.98

0.11

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

616

0.96

0.11

1.1

1.3

mmol/l

6.0

6.1

0.04

587

(3008402) Methanol [Moles/volume] in Serum or Plasma

138

0.90

0.11

1.2

1.3

mmol/l

—

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

145

0.91

0.11

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.12

0.10

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.14

0.10

1.3

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.11

0.10

6.8

2.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

106

0.89

0.09

3.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

425

3060

1.01

0.09

1.4

mmol/l

3.8

0.52

396

2885

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.08

1.0

—

(3020650) Glucose [Presence] in Urine

337

0.95

0.08

1.3

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

651

1.03

0.08

1.0

1.1

u/l

1.1

0.16

320

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

143

0.92

0.08

1.1

ug/l

115.5

81.6

1.51

111

(40760410) HLA-B [Type] by High resolution

0.78

0.08

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.78

0.08

1.0

—

(40760409) HLA-A [Type] by High resolution

0.78

0.08

1.0

—

(40763590) HLA-DQ beta [Type]

0.78

0.08

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

105

0.90

0.08

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2572

18689

1.00

0.08

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

171

1.07

0.07

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

114

1.09

0.07

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

127

0.92

0.07

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

181

1344

0.98

0.07

1.1

—

77.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

215

1.05

0.06

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

739

0.98

0.06

4.0

5.5

u/ml

44.0

5857.1

—

138

(3027231) Wheat IgE Ab [Units/volume] in Serum

207

0.95

0.05

1.1

—

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

168

1244

0.99

0.05

1.7

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

368

1.03

0.05

1.8

2.1

mg/l

7.4

9.6

2.52

297

(3041672) Baker's yeast Ab [Presence] in Serum

1.11

0.04

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.92

0.04

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

193

1392

1.01

0.04

3.1

3.8

u/ml

35.4

57.1

2.11

187

1371

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

124

1.06

0.04

1.5

1.2

mmol/l

21.6

20.5

0.53

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

117

866

0.99

0.03

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

103

1.06

0.03

1.3

1.6

46.9

35.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

161

1163

1.01

0.03

4.7

5.1

u/ml

108.8

114.7

0.03

351

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

132

1.05

0.03

1.1

1.2

16.1

24.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

101

0.94

0.02

1.5

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

270

0.97

0.02

2.9

6.1

u/l

49.0

69.9

0.49

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

379

1.02

0.02

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.93

0.02

3.3

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

373

1.02

0.01

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

162

1190

0.99

0.01

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

371

0.98

0.01

1.5

1.8

—

(4198724)

385

0.99

0.01

1.8

2.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

114

0.96

0.00

1.2

1.3

nmol/l

21.5

15.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

155

1126

1.00

0.00

1.4

nmol/l

0.4

0.3

0.47

108

841

(3004446) Plasmodium sp identified in Blood by Light microscopy

108

1.01

0.00

1.8

2.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

375

0.99

0.00

2.7

3.6

mg/l

6.7

7.5

0.44

304

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

522

0.99

0.00

3.0

umol/l

31.1

28.2

1.50

401

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.01

0.00

1.2

1.0

—

(44806071)

163

0.98

0.00

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.00

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

341

1.01

0.00

2.3

3.0

au/ml

270.6

163.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.03

0.00

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

379

1.00

0.00

1.2

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.04

0.00

3.2

3.5

—

0.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

0.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3013762) Body weight Measured

1.02

0.00

1.2

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.99

0.00

1.0

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.93

0.00

1.3

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_NONRHEVALV and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_NONRHEVALV	1.736 [1.59, 1.89]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.055

During the follow-up period (1.1.1998 — 31.12.2019), 31028 out of 80329 females with I9_NONRHEVALV died.

Males

Parameter	HR [95% CI]	p-value
I9_NONRHEVALV	1.699 [1.55, 1.87]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 28903 out of 78811 males with I9_NONRHEVALV died.

Mortality risk

Mortality risk for people of age

years, who have I9_NONRHEVALV.

N-year risk	Females	Males
1	0.163%	0.268%
5	0.874%	1.582%
10	2.138%	3.94%
15	4.021%	7.365%
20	6.991%	12.656%

Relationships between endpoints

↥

Index endpoint: I9_NONRHEVALV – Non-rheumatic valve diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Non-rheumatic valve diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints